UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934 FOR THE FISCAL YEAR ENDED JUNE 30, ~~2017~~2018

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO

Commission file number 333-198993

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

(Name of small business issuer in its charter)

Wyoming	7812	45-5552519
(State or other jurisdiction of incorporation or organization)	(Primary Standard Industrial Classification Code Number)	(I.R.S. Employer Identification Code Number)

~~2173~~2721 ~~Salk~~Loker Avenue, ~~Suite 250,~~West

Carlsbad, CA ~~92008~~92010

(760) ~~456~~444-~~5777~~5566

www.~~GreenMeadowProducts~~OptecIntl.com

(Address and telephone number of registrant’s principal executive offices and principal place of business)

1010 Industrial Road, Suite 70

Boulder City, Nevada, 89005

702-769-4529

--------------------------------------------------

(Former Address and telephone Number of principal executive offices)

Securities registered under Section 12(b) of the Exchange Act: None

Securities registered under Section 12(g) of the Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (¤232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (¤229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer o☐ Accelerated filer o☐ Non-accelerated filer (Do not check if a smaller reporting company) o☐ Smaller reporting company x☒ Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No x☒

~~Number~~Aggregate ofmarket ~~shares~~value of registrant’s common stock ~~outstanding~~held atby ~~June~~non-affiliates 30of the registrant on December 31, 2017:, 52based upon the closing price of Common Stock on such date as reported by OTCQB Market,~~944~~ was approximately $14,~~500~~764,750. ~~(as~~Shares ~~restated~~of ~~for~~common 7stock ~~for~~known 1to ~~forward~~be ~~split~~owned by directors and executive officers of the ~~Company's~~Registrant ~~common~~subject ~~stock~~to ~~completed~~Section ~~effective~~16 ~~June~~of 1,the ~~2015)~~Securities Exchange Act of 1934 are not included in the computation. No determination has been made that such persons are “affiliates” within the meaning of Rule 12b-2 under the Exchange Act.

Number of shares of common stock outstanding at October 11, 2018: 17,829,947 (as restated for 7 for 1 forward split of the Company's common stock completed effective June 1, 2015).

Documents incorporated by reference: None.

TABLE OF CONTENTS

ITEM 1. DESCRIPTION OF BUSINESS.	31
ITEM 1A. RISK FACTORS	127
ITEM 2. DESCRIPTION OF PROPERTY.	128
ITEM 3. LEGAL PROCEEDINGS.	128
ITEM 4. MINE SAFETY DISCLOSURES.	128
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.	139
ITEM 6. SELECTED FINANCIAL DATA.	139
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	1410
ITEM 8. FINANCIAL STATEMENTS.	19F-1
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.	3216
ITEM 9A. CONTROLS AND PROCEDURES.	3216
ITEM 9B OTHER INFORMATION	3318
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.	3418
ITEM 11. EXECUTIVE COMPENSATION.	3519
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.	3620
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.	3621
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES	3721
ITEM 15. EXHIBITS AND REPORTS ON FORM 8-K	3722
SIGNATURE PAGE	3823

Certain Terms Used in this Report

For purposes of this report, unless otherwise indicated or the context otherwise requires, all references herein to “Optec International, Inc.”,Optec”, "Green Meadow Products," "GM," "the Company," "we," "us," and "our," refer to Optec International, Inc. (Formerly Green meadow Products, Inc.) a Wyoming corporation.

Forward-Looking Statements

The following discussion contains forward-looking statements regarding us, our business, prospects and results of operations that are subject to certain risks and uncertainties posed by many factors and events that could cause our actual business, prospects and results of operations to differ materially from those that may be anticipated by such forward-looking statements. Factors that may affect such forward-looking statements include, without limitation: our ability to successfully develop new products and services for new markets; the impact of competition on our revenues, changes in law or regulatory requirements that adversely affect or preclude clients from using us for certain applications; delays our introduction of new products or services; and our failure to keep pace with our competitors.

When used in this discussion, words such as "believes", "anticipates", "expects", "intends" and similar expressions are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may subsequently arise. Readers are urged to carefully review and consider the various disclosures made by us in this report and other reports filed with the Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that may affect our business.

PART I

ITEM 1. DESCRIPTION OF BUSINESS.

Statements in this Form 10-K Annual Report may be "forward-looking statements." Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by our management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in this Form 10-K Annual Report, including the risks described under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and in other documents which we file with the Securities and Exchange Commission.

In addition, such statements could be affected by risks and uncertainties related to our financial condition, factors that affect our industry, market and customer acceptance, competition, government regulations and requirements and pricing, as well as general industry and market conditions and growth rates, and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Form 10-K Annual Report.

DESCRIPTION OF BUSINESS

Overview

Optec International, Inc. (Formerly Green Meadow Products, Inc.) "~~GMP~~the Company", ~~the~~ "~~Company~~GMP", "we", "us" or "our" ~~“Optec”~~) was incorporated inunder the ~~State~~laws of ~~Wyoming~~the onState ~~June 22~~ of ~~2012.~~Wyoming ~~The Company initially acquired a product for trucking fleets~~ on ~~December~~June 2022, 2012. Subsequently on April 18, 2013, we made the decision to take the business in a different direction and sold the product for the trucking fleets at a loss. The Company's new focus was, and is, on the manufacturing and sales of natural products for the pet industry. The Company acquired a formula for natural pain relief for animals on February 27, 2013 for consideration of $10,500, which was satisfied through the payment of $500 in cash and the issuance of 700,000 shares of our common stock valued at $0.014 per share, with the intent to manufacture the product for wholesale and retail distribution. We have subsequently named the product, Green Meadow PR formula. The acquisition gave the Company all rights surrounding the formula with no additional royalties, or any other payment due.

InThe ~~addition~~Company distributes products in what we ~~have~~consider ~~acquired~~to ~~Optec~~be the “Green Sector” or “environmentally friendly sector”. In the last year the Company has focused its resources towards the sales of The Optimized Fuel Maximizer, ~~devices~~an ~~which~~on wedemand ~~have~~technology ~~tested~~designed for computer controlled gasoline and diesel engines for improved fuel efficiency and performance while simultaneously reducing harmful emissions. We believe that the technology can reduce greenhouse gas emissions which ~~fit~~in ~~within~~turn could conceivably aid in making the air much healthier in our ~~concept~~cities. (For offurther ~~environmentally~~information ~~friendly~~on ~~products~~Optec Products acquired-www.optecmpg.com).

InOn June 4, 2018 the ~~last~~Company ~~year~~entered ~~ending~~into ~~June~~an ~~30,~~Exclusive ~~2017~~Licensing Agreement with Optimized Fuel Technologies, wea ~~have~~related ~~done~~party, ~~marketing~~for ~~testing~~the ofright ~~organic~~to ~~dog~~exclusively ~~treats~~distribute inand sell the ~~attempt~~Optimized toFuel ~~perfect~~Maximizer ainternationally, ~~treat~~with ~~formula~~the ~~which~~exception isof ~~appealing~~the toUnited ~~dogs~~States ~~using~~and aCanada. ~~variation~~Consideration of ~~our~~$501,500 ~~pain~~was ~~relief~~paid ~~formula~~for the licensing right in the ~~treats.~~form Weof ~~anticipate~~one ~~expanding~~million ~~the~~five ~~development~~hundred thousand (1,500,000) shares of ~~our~~the ~~dog~~Company’s ~~treat~~common ~~formula~~shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies; in addition to five hundred thousand dollars ($500,000) to be paid over the ~~next~~course ~~year~~of ~~ultimately~~24 ~~with~~months from the ~~goal~~date herein; of ~~expanding~~which ~~sales~~the ~~nationally~~Company ~~and~~has ~~internationally~~paid $109,000.

AsOn aJune ~~result~~20, ~~our~~2018 ~~plan~~the isCompany toentered ~~initiate~~into ~~the~~an ~~manufacturing~~Exclusive ofLicensing ~~the~~Agreement ~~natural~~Addendum ~~pain~~with ~~relief~~Optimized ~~product~~Fuel ~~based~~Technologies onfor the ~~formulation~~right ofto ~~the~~exclusively ~~Green~~sell ~~Meadow~~the PROptimized ~~formula~~Fuel ~~which~~Maximizer weworldwide. ~~acquired~~On asJune ~~well~~4, as2018, ~~to initiate~~ the ~~manufacturing~~Company ofhad ~~pet~~entered ~~treats~~into ~~using~~an ~~the~~Exclusive ~~same~~Licensing ~~formula~~Agreement aswith inOptimized ~~our~~Fuel ~~pain~~Technologies ~~relief~~for ~~formula.~~the ~~Currently~~right weto ~~are~~exclusively insell ~~search~~the ofOptimized aFuel ~~manufacturer~~Maximizer ~~that~~internationally, ~~would~~with ~~meet~~ the ~~specifications~~exception weof ~~require.~~the ~~Primarily~~United aStates ~~manufacturer~~and ~~that~~Canada; ~~currently~~this ~~manufactures~~agreement ~~natural~~extends ~~pet~~exclusive ~~products~~marketing ~~while~~right atto ~~the~~include ~~same~~North ~~time~~America ~~being~~and ~~able~~Canada. toConsideration doof so$1,000 atwas apaid ~~cost~~for ~~effective~~the ~~price~~licensing ~~point.~~rights Weunder ~~anticipate with~~ the ~~proper~~addendum ~~funding~~in ~~(which~~the atform ~~this~~of ~~time~~one ismillion ~~an unknown~~(1,000,000) ~~that~~shares weof ~~will be in~~ the ~~process~~Company’s ofcommon ~~manufacturing~~shares ~~and~~valued ~~sales~~at of$.001 ~~our~~per ~~pain~~share ~~relief~~which ~~products~~were ~~and~~authorized ~~pain~~to ~~relief~~be ~~treat~~issued into ~~the~~Optimized ~~year~~Fuel ~~2017-2018~~Technologies.

WeOn ~~have~~August ~~also~~8, ~~developed~~2018 ~~the~~Optimized ~~"PawPal"~~Fuel ~~which~~Technologies, is a ~~foam~~related ~~pad~~party, ~~with~~entered into a ~~removable~~contract ~~cover~~with ~~for~~a ~~dogs.~~company ~~The~~that ~~pad~~desired ~~was developed~~ to bepurchase ~~used~~the ~~for~~Optimized ~~dogs~~Fuel ~~when~~Maximizer ~~they~~on ~~jump out of~~ a ~~car~~manufacturer ordirect ~~down~~basis. ~~from~~As athe ~~high~~Company ~~object~~owns ~~such~~the asexclusive alicensing ~~couch~~rights ~~or bed,~~ to ~~relieve~~sales of the ~~stress~~Optimized onFuel ~~joints~~Maximizer; ~~from~~per the ~~impact~~Royalty ofagreement ~~landing.~~dated WeAugust ~~have~~27, ~~designed~~2018 the ~~pad~~Company ~~with~~agreed ~~high~~to ~~density~~the ~~foam~~acceptance ~~and~~of aroyalty ~~tough~~revenue ~~removable~~generated ~~poly~~by ~~cover~~sales which ~~can~~are bemade ~~washed~~on a manufacturer direct basis.

~~Many~~We ~~people~~are ~~take~~currently ~~their~~expanding ~~dogs~~our ~~out~~marketing ~~into~~efforts ~~the outdoors, the dog jumps out of the car~~ and ~~depending~~sales ~~on the type~~ of ~~terrain, joints can be impacted from~~ the ~~result~~Optimized ofFuel ~~the~~Maximizer ~~jump or paws can be damaged from debris~~units. ~~This is especially the case in older dogs and dogs with hip dysplasia. The pad is lightweight and takes up little room and can be easily cleaned.~~

WePreviously ~~believe~~the ~~that~~Company had engaged in the ~~PawPal~~sales isof apet ~~perfect~~pain ~~companion~~relief ~~with~~products and licenses for the ~~Green~~formulation ~~Meadow~~of PRpet ~~formula~~products. ~~The~~While ~~PawPal~~the ~~can~~Company bestill ~~used~~retains asownership anof ~~aid~~the inpain ~~preventing~~relief ~~injury~~product asfor ~~well~~pets, asthat sector of business is no longer the ~~Green~~focal ~~Meadow~~point PRof ~~formula~~the ~~should~~Company. ~~injury~~The ~~occur~~company orexpects to sell off the formulation for ~~dogs~~the ~~that~~pet ~~are~~pain ~~older~~relief ~~and~~product ~~have~~in ~~arthritic~~the ~~type~~next ~~conditions~~quarter.

~~The~~Optimized ~~prototypes~~Fuel ~~have~~Maximizer been manufactured in Mexico. We anticipate manufacturing and sales of the PawPal to commence sometime in 2017. However development and sales will be dependent on the proper funding; at this time we have no commitments for any type of funding whether it be debt or equity financing.Product

In the year ended June 30, 2017, we made a decision to review additional potential products for marketing and distribution in what we consider to be the “Green Sector” or “environmentally friendly” which would fit within our guidelines as environmentally friendly products. As a result we acquired seven Optec Fuel Maximizer devices for vehicles in March of 2017 for testing; comprised of 2 HD Optec Fuel Maximizers, 2 Intermediate Optec Fuel Maximizers, 1 Optec Fuel Maximizer for gas passenger cars, 1 Optec Fuel Maximizer for diesel passenger cars. The Optec Fuel Maximizer is an on demand technology designed for computer controlled gasoline and diesel engines for improved fuel efficiency while simultaneously reducing harmful emissions. We believe that the technology can reduce greenhouse gas emissions which in turn could conceivably aid in making the air much healthier in our cities. Should the Company’s testing of the devices prove to meet the claims of the manufacturer, we may enter into future discussions with Optec for potential licensing rights for the devices. (For further information on Optec Products acquired-www.optecmpg.com)

Pet Pain Relief Product

Sales and Marketing

In the last year we have marketed the product and have done marketing testing ofwith ~~organic~~some ~~dog~~minimal ~~treats~~sales inof the ~~attempt~~Optimized Fuel Maximizer in order to ~~perfect~~aid athe ~~treat~~manufacturer ~~formula~~in ~~which~~the isfinal ~~appealing~~product todevelopment. ~~dogs~~In ~~using~~that aprocess ~~variation~~we ofhave ~~our~~sold ~~pain~~$85,100 ~~relief~~of ~~formula~~product internationally in the ~~treats.~~last Weyear ~~anticipate~~for ~~expanding~~vehicles. Additionally, the ~~development~~product ofwas ~~our~~tested ~~dog~~on ~~treat~~truck ~~formula~~refrigeration insystems, ~~the~~generators ~~next~~and ~~year~~large ~~ultimately~~off ~~with~~road ~~the~~diesel ~~goal~~trucks ofin ~~expanding~~order ~~sales~~to ~~nationally~~best ~~and~~determine ~~internationally~~our marketing strategies moving forward.

In the past our revenues have come from the sale of the sub-licensing rights to the Green Meadow PR formula, the sale of the non-exclusive design rights of the PawPal and the retail sale of the pain relief product, Petaprin, in our market testing. We also sold our discontinued operations initial product for trucking fleets at a loss as we determined that we would focus on the sales of licensing rights to our Green Meadow PR formula and the manufacturing and sales of our Green Meadow PR formula as well as the manufacturing and sales of our PawPal product.2

~~Selling~~The the licensing rights for the Green Meadow PR formula was a direction taken by us to aid in the capitalization of the Company. We intend to market our products in the United States under our label. None of the licensing rights previously sold to other companies prevent us from selling the Green Meadow PR formula under our own Green Meadow Products brand within the United States, while at the same time preventing those companies that we did market the product tohas ~~from~~been ~~competing~~updated ~~against us in the United States with the exception of Eastwinds Holding Corporation (as detailed below)~~ and ~~Sandstone~~is ~~Enterprises.~~currently ~~Sandstone~~being ~~Enterprises~~marketed ~~acquired the distribution rights~~ for ~~the product in the states of Virginia and North Carolina. (For further details please see "Competition.").~~:

OnPassenger ~~January~~Vehicles 21(cars, ~~2014,~~small wetrucks ~~signed a contract with Wholesale 4 You, Inc. whereby Wholesale acquired the licensing rights to manufacture~~ and sell the pain relief product in Central and South America for the sum of $15,000. There are no royalties attached to the rights. The rights are exclusive to Central and South America only. The rights have no duration or termination constraints.SUVs)

OnIntermediate ~~February~~/ ~~28,~~Medium ~~2014,~~duty ~~we entered into a contract for the rights to our Green Meadow PR formulation with Mountain High Products, Inc.~~ Trucks

InOff-Road ~~February~~equipment ofas ~~2014,~~well weas ~~entered~~Generator into a contract with a distributor to sell the product in Virginia and North Carolina for the sum of $6,000. There were no royalties attached to the rights and the rights are exclusive to Virginia and North Carolina. The rights have no duration or termination constraints.systems

OnHeavy ~~March~~Duty ~~28,~~Diesel ~~2014,~~On-Road weVehicles ~~entered into an exclusive licensing rights contract with Mountain High, Inc for the rights to manufacture~~ and ~~sell~~Transportation ~~both~~Refrigeration ~~the Paw Pal product and the Green Meadow PR formula internationally with the exception of Central and South America for the sum of $20,000. The rights have no duration or termination constraints.~~Units

OnOur ~~September~~marketing ~~18,~~efforts ~~2014,~~target welarger ~~entered~~distributors ~~into a contract with Eastwinds Holding Corporation ("EWH") for the non-exclusive sub-licensing rights to manufacture and sell our Green Meadow PR formula in the United States with the exception~~ of ~~Virginia~~automotive ~~and~~products ~~North~~as ~~Carolina,~~well ~~for~~as ~~the~~larger ~~sum~~fleets of ~~$15,000.~~vehicles ~~There~~such are no future royalties attached to the sale of these rights. Under the terms of the contract we were required to deliver all details, digital information, specifications and samples of the Green Meadow PR formula upon acceptance of the contract and upon receipt of the $15,000 payment, which we have done. We have no further obligations under the contract. Accordingly, we have recognized in full the $15,000 received from the sale of these non-exclusive licensing rights as ~~revenue during the period. The rights have no duration or termination constraints.~~:

We· ~~sold~~Automotive ~~the~~parts licensing rights to Eastwinds Holding Corporation (EWH) for the United States with the stipulation that EWH would private label the product and that we would have the right to purchase the product from EWH if we so chose at EWH's cost plus 10% (of the price EWH receives the product from the manufacturer, including packaging, but not labeling or shipping). Under the terms of the agreement, should we purchase the product from EWH, we would private label the product. Further, that if we should establish a manufacturer and both parties are in agreement, EWH shall have the right to purchase the product from us at a price of cost plus 15% (of the price GM receives the product from the manufacturer, including packaging, but not labeling or shipping).stores

5· Police Forces

~~Green~~· ~~Meadow~~Fire ~~Pain Relief formula~~Departments

We· plan on initiating the manufacturing of the natural Green Meadow PR formula based on the formulation which we acquired. We are in search of a manufacturer that would meet the specifications we require; a manufacturer that currently manufactures natural pet products while at the same time being able to do so at a cost effective price point.UPS

Federal Express

DHL

Knight Trucking fleets

And additional car or truck fleets both internationally and nationally

Product Description

~~The~~Image ~~Green Meadow PR Formula is a formula specifically for canines and felines. ETArol (tm), the freeze-dried whole extract~~ of ~~the~~different ~~New Zealand Green Lipped Mussel, is the active ingredient in a supporting blend of nutritive herbs. The Green Lipped Mussel is a source of glucosamine, chondroitin and glycosaminoglycans.~~models

~~These natural joint health ingredients combined with omega-~~3 ~~essential fatty acids are found in Green Lipped Mussel. ETArol(tm) also contains many nutrients and trace elements important for the health of dogs or cats.~~

AsThe ~~there~~Optimized ~~are~~Fuel noMaximizer, ~~studies~~is an on ~~the~~demand ~~formula,~~technology ~~there~~designed isfor nocomputer ~~certainty~~controlled ~~that~~gasoline ~~the~~and ~~formula~~diesel ~~can~~engines orfor ~~cannot~~improved befuel ~~helpful~~efficiency towhile ~~dogs~~simultaneously ~~and/or~~reducing ~~cats~~harmful byemissions ~~using~~and ~~the~~enhancing ~~Green Meadow PR Formula~~performance.

~~Ingredients~~The Optimized Fuel Maximizer is manufactured by Optimized Fuel technologies in the USA.

The ~~Green~~product ~~Meadow~~is PRa ~~formula~~small, ~~contains:~~non-intrusive system that connects to an engines fuse box and source of vacuum. It requires no tanks or water reservoirs. By definition the Optimized Fuel Maximizer is a hydrogen fuel cell and it’s function is to emit a micro amount of hydrogen and cooler air into the combustion chamber to complete the combustion of the fuel. The technology is fully patented by the manufacturer and has undergone rigorous third-party testing to support performance claims and engine safety. The cost for installation of the system varies depending on the type of vehicle or generator it is being added to.

~~· ETArol(tm)~~The -product ~~Exclusive~~was ~~Green~~designed ~~Lipped~~for ~~Mussel~~three ~~Extract~~different ~~used as a major source of glucosamine,~~applications

· Chondroitin and glycosaminoglycans.

	Unit Type		Application
	PSV38D		Diesel passenger vehicles and light duty trucks
	PSV38G		Gasoline passenger vehicles and light duty trucks
	MD374		Diesel Medium Duty weight class vehicles
	MD374G		Gasoline Medium Duty weight class vehicles such as delivery vans
	HD386		Heavy Duty Diesel engines including on-road and off-road applications
	TRU386		Transportation Refrigeration Units

~~· Ginger~~The ~~Powder~~state -of California requires all aftermarket parts to be tested and approved for the legal sale and installation. The Optimized Fuel Maximizer has been in testing for three years and has received an executive order for the legal sale of the product for various diesel engines. Currently the Optimized Fuel Maximizer is unavailable in the state of California for gasoline vehicles but is in the application process of obtaining the addition of these engines.

· Green Tea Extract - Green tea is rich in catechin polyphenols (GTC), particularly epigallocatechin

· gallate (EGCG). EGCG is an anti-oxidant:

· Holy Basil Extract – An antioxidant

· White Willow Bark Extract -

· Skullcap Extract-

· Turmeric Extract - Curcumin is the part of turmeric that gives curry food its golden color and provides turmeric with curcuminoids.

· Feverfew Extract - An herb -

· Rosemary Extract - Another antioxidant.

Other Ingredients: Rice Flour, DiCalcium Phosphate, Natural Liver Flavor, Molasses, Stearic Acid, Magnesium Stearate. There are no artificial preservatives, no salt, no fat, no wheat, no chemicals, no caffeine, and no artificial colors or flavors in the formulation.

Upon completion of the manufacturing process we plan on marketing the product on a wholesale level to larger retail pet distributors as well as to veterinarians and pet stores.

We also plan on marketing the product on a retail level through our website. We plan on using social media in our marketing efforts such as:

Twitter

Facebook

Instagram

Statista (The Statistics Portal) indicates there were 1.41 billion social network users worldwide in 2012 and projects that number to increase to 2.33 billion users by 2017.

We believe that marketing the natural pain relief product in a desirable (by pets) chewable tablet form using the internet and social media will be a cost effective marketing plan.

Our pain relief product could be classified as a drug and subsequently regulated by the food and drug administration.

The FDA may classify our pain relief products as a drug specifically because in our efforts to market or sell our pain relief product, we state here and elsewhere that our pain relief product may be used as a pain relief product in the pet industry. If our product was considered a "drug" under section 201(g) of the Act, the FDA (Food and Drug Administration) could seek to take enforcement action against us if we were deemed to be marketing an unapproved new animal drug. In addition if our product was considered a "drug" under section 201(g) of the Act the FDA it could be deemed to be a "new animal drug," as defined under section 201(v) of the Act because it may not be generally recognized among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. If our product were deemed to be a "new animal drug," as defined under section 201(v) of the Act, to be legally marketed as a new animal drug we must have an approved new animal drug application, conditionally approved new animal drug application, or index listing under sections 512, 571, and 572 of the Act. We have not applied for any such approvals from the FDA. We have no intention to apply to the FDA for approval for our pain relief product.

If our product was found to be a "drug" under section 201(g) of the Act by the FDA (Food and Drug Administration), we would be forced to stop any production and sales of the product which could adversely affect our business, financial condition or results of operations. Further, we may face potential liability for selling our product as a "drug".

PawPal

Currently, we have developed prototypes of the PawPal by a manufacturer in Mexico. We believe that to manufacture a quality cost effective product, we must find a manufacturer that will complete the product per our specifications. At this time, we are not certain the manufacturer in Mexico will be the manufacturer we will continue to use. Once we have determined the optimum manufacturer for the PawPal product and have initiated the manufacturing of the product we will initiate sales aligned with the selling of the Natural Pain relief product.

Industry Overview

The ~~pet~~Global ~~market~~Automotive isaftermarket ~~dominated~~size byin a2016 ~~number~~was of$640B+ ~~very large retailers such as Petco~~ and ~~Petsmart~~there tois ~~name~~ a ~~few~~4.7% ~~Natural~~market ~~pet~~growth ~~remedies~~rate ~~are~~expected ~~sold~~to byreach ~~most veterinarians, pet stores and larger pet retail outlets~~$847.15B Asby ~~the following chart portrays the pet market in the U.S. alone is a large market.~~2022

7· “Asia-Pacific is anticipated to be the fastest growing market with a CAGR of about 6.5%.

~~The~~· ~~following~~In UEurope, products which enhance the performance and agility features of the vehicle are expected to show highest growth.S There are 751.4M+ ~~pet~~motor ~~industry~~vehicles ~~statistics~~in ~~are~~operation ~~gathered~~outside ~~from~~of the ~~APPA~~U.S ~~(American~~and ~~Pet~~29M ~~Products~~number ~~Association)~~of commercial vehicle sales globally in 2017.

~~Total~~(*Source ~~U.S.~~the ~~Pet~~Global ~~Industry~~Automotive ~~Expenditures~~Aftermarket Products market by Research and Market Reports)

YEAR	(billion $)
2014	$	58.51 Estimated
2013	$	55.72
2012	$	53.33
2011	$	50.96
2010		48.35
2009	$	45.50
2008	$	43.20
2007	$	41.20
2006	$	38.5
2005	$	36.30
2004	$	34.40
2003	$	32.40
2002	$	29.50
2001	$	28.50
1998	$	23
1996	$	21
1994	$	17

With the ever-tightening emission and fuel regulations on auto manufacturers, coupled with the increase in demand by consumers for a higher performing vehicle, there is a pressing need for innovative technologies like the Optimized Fuel Maximizer to fulfill both demands.

~~Estimated 2014 Sales within the U.S. Market~~4

~~For~~Beyond ~~2014~~vehicle manufactures, itthere is ~~estimated~~an ~~that~~extremely ~~$58~~high demand from fleet operators, municipalities, and consumers to save fuel and reduce emissions with their existing engines.51 ~~billion~~The ~~would~~cost befor ~~spent~~retrofitting onor ~~our~~buying ~~pets~~new inhybrid ~~the~~or Uelectric engines are just too high for many business and consumers, and there is a desperate need to reduce operation cost and comply with emission standards.S.

~~Estimated~~Money ~~Breakdown~~and business aside, the public is demanding cleaner, safer air because air pollution is steadily getting worse in many parts of the world. Approximately seven million people are dying every year due to poor air quality and there has never been more of a need for technology like OPTEC. (Source: World Health Organization) As a global population, there is a huge problem with pollution and air quality. Increasingly more countries are recognizing this problem at a rapid rate and, in turn, seeking innovative technologies like the Optimized Fuel Maximizer.

Breakdown	(billion $)
Food	$	22.62
Supplies/OTC Medicine	$	13.72
Vet Care	$	15.25
Live animal purchases	$	2.19
Pet Services: grooming & boarding	$	4.73

The recognition of this problem, caused predominantly by fossil fuel usage, are causing countries to work together to reduce emissions.

~~Actual~~· ~~Sales~~OPTEC ~~within~~International ~~the~~works ~~U.S.~~tirelessly ~~Market~~to be in ~~2013~~close contact with these countries to discover solutions that will hopefully become a major breakthrough for generations to come.

InAutomotive ~~2013, $55.72~~Aftermarket ~~billion was spent on our pets in the U.S.~~Industry

Breakdown:	(billion $)
Food	$	21.57
Supplies/OTC Medicine	$	13.14
Vet Care	$	14.37
Live animal purchases	$	2.23
Pet Services: grooming & boarding	$	4.41

The global automotive aftermarket industry is expected to reach $722.8 billion by 2020. Today’s consumers are keeping their vehicles longer and are more aware of the importance of preventive maintenance and scheduled servicing to maximize the lifetime value of their vehicles. This rising demand for aftermarket parts and services is spurring new growth and revenue opportunities for a wide range of businesses operating in the automotive aftermarket industry.

~~GMP~~Trends ~~is cognizant of the intense competition~~ and the industry trends and management has attempted to devise its business strategy to exist and survive within the realities of this new marketplace. The charts are meant to portray the overall expenditures on pets. We are not aware of what percentage of the expenditures in the previous charts are directed towards the specific amounts spent on animal dietary supplements to treat pain or specific pet products to help prevent pain; nor are we aware of any statistics that specifically address those markets in which we compete.Statistics:

8· The average age of the U.S. vehicle fleet has increased 17% in the last ten years.

The average length of vehicle ownership for new and used vehicles has increased 60% in the last ten years.

75% of aftermarket auto repair is performed by independent auto repair shops, while 25% of the business lives with dealerships.

There’s a trend toward large franchise auto repair businesses, which have smaller shops rolling up into them. That’s a good opportunity for profitable businesses on the service/seller-side.

The aftermarket world is going online, and the marketplace is changing. Parts are being sold online, service is being sold online.

(Source: May 24, 2018-V12DATA- https://www.v12data.com/blog/a-look-at-trends-and-statistics-in-the-automotive-aftermarket-industry-2017/)

Industry Insights

The global automotive aftermarket size was valued at USD 335.23 billion in 2016 and is projected to gain traction over the forecast period. The market is majorly driven by automobile drivers looking to enhance vehicle performance in terms of exhaust, sound, speed, and appearance, among other aspects.

Regional regulatory authorities, such as Japanese Automobile Sports Muffler Association (JASMA) and the U.S. Environmental Protection Agency, monitor built-up standards and environmental impacts associated with automotive component functioning. Noise emission levels associated with modern-day automotive resonators and mufflers in automotive exhaust systems is one such example.

The automotive aftermarket service channel comprises raw material suppliers, tier 1 distributors, automobile exhaust hubs/manufacturing units, aftermarket units comprising jobbers, and repair shops, among others. Repair centers are the important stakeholders in the service channel. Source: Grand View research https://www.grandviewresearch.com/industry-analysis/aftermarket-automotive-parts-market

Competition

~~The~~To ~~pet~~our ~~medications~~knowledge ~~market~~we isdo ~~competitive~~not ~~and~~have ~~highly~~any ~~fragmented. Our~~direct competitors ~~consist~~in the space that can provide the benefits of ~~veterinarians~~emission reduction, fuel savings, and ~~online~~an increase in performance. Though there have been past attempts at small hydrogen generators, all have required water reservoirs or hydrogen storage tanks. The Optimized Fuel Maximizer does not require either of these and ~~traditional~~successfully ~~retailers~~achieves results with just a micro amount of hydrogen. We ~~believe~~The ~~that~~hydrogen ~~the~~is ~~following~~created ~~are~~from ~~the~~ambient ~~principal~~air ~~competitive~~and ~~factors~~this inis ~~our~~what ~~market:~~makes it unique.

~~● Product selection and availability, including the availability of prescription and non-prescription medications;~~6

● Brand recognition;

● Reliability and speed of delivery;

● Personalized service and convenience;

● Price; and

● Quality of website content.

We will compete with veterinarians, pet retailers such as Petsmart and Petco as well as many online retailers of pet products for the sale of our natural pain relief products who sell prescription and non-prescription pet medications and other health products.

We intend to market our products in the United States. None of the licensing rights previously sold to other companies prevent us from selling the Green Meadow PR formula under our own Green Meadow Products brand within the United States, while at the same time preventing those companies that we did market the product to from competing against us in the United States with the exception of Eastwinds Holding Corporation and Sandstone Enterprises, which acquired the licensing rights to distribute the product in North Carolina and Virginia (however we retain the right to sell the product under our label in those states).

We sold the licensing rights to Eastwinds Holding Corporation (EWH) for the United States with the stipulation that EWH would private label the product and that we would have the right to purchase the product from EWH if we so chose at EWH's cost plus 10% (of the price EWH receives the product from the manufacturer, including packaging, but not labeling or shipping). Under the terms of the agreement, should we purchase the product from EWH, we would private label the product. Further, if we should establish a manufacturer and both parties are in agreement, EWH shall have the right to purchase the product from us at a price of cost plus 15% (of the price GM receives the product from the manufacturer, including packaging, but not labeling or shipping).

Selling the rights to EWH could affect our ability to successfully market the product even though both EWH and GM would be selling the product under their own label. Regardless, EWH would be a direct competitor for the United States Market which could impact our ability to successfully market the product under our label.

There are similar products to ours which are available from numerous other sources, including other distributors and manufacturers. Consolidation in the animal health products industry could result in existing competitors increasing their market share, which could give them greater pricing power, decrease our revenues and profitability, and increase the competition for customers. We purchase our current pain relief product, Petaprin, which is private labeled for us, from Vitanique who is also a direct competitor as they sell the same product under their name.

Many pet owners may prefer the convenience of purchasing their pet medications or other health products at the time of a veterinarian visit. In order to effectively compete with veterinarians, we must continue to educate pet owners about the potential benefits of a natural pain relief product, convenience, and savings offered by our Company.

According to the American Pet Products Manufacturers Association, pet spending in the United States is estimated to have increased 4.7% to $58.51 billion in 2014. Pet supplies and medications represented $13.6 billion, or 25% of the total spending on pets in the United States. The pet medication market that we participate in is estimated to be approximately $4.4 billion, with veterinarians having the majority of the market share. The dog and cat population is approximately 165 million, with approximately 62% of all households having a pet.

We believe that the following are the main competitive strengths that will differentiate our products from the competition:

● All natural product;

● With our formula, a chewable tablet that pets will potentially eat as they would a treat;

● unique "niche" products inclusive of our Green Meadow PR formula as well as out PawPal.

There are similar products to ours available from numerous other sources, including other distributors and manufacturers. We have not done a market study to determine all of the product lines which are similar to ours. We will compete with veterinarians, large pet retailers such as Petsmart and Petco as well as many online retailers of pet products for the sale of our natural pain relief products who sell prescription and non-prescription pet medications and other health products.

While our Green Meadow PR formula offers a formula comprised of the ingredients, elaborated under Product Description, in a specific formulation, there are many other companies that offer products with some or all of the same ingredients in different formulations. We do not know the exact formulation of our competitors. As such there may be competitors that offer the exact formulation or that offer a product with similar ingredients in a different formulation.

The Company does not intend to directly compete against the larger pet retailers and manufacturers, and it will not attempt to finance any projects beyond the limited scope of its business plans and on emerging distribution opportunities. Regardless, it will still have competition from a wide range of even smaller online distributors of pet products as well as the veterinarians and pet stores, all more established and, in most instances, better capitalized than the Company.

Regulation

Our ~~businesses~~Company ~~are~~is regulated by governmental authorities in the jurisdictions in which we operate. Because of our international operations, we must comply with diverse and evolving regulations. Regulation relates to, among other things, management, licensing, foreign investment, use of confidential customer information and content. Our failure to comply with all applicable laws and regulations could result in, among other things, regulatory actions or legal proceedings against us, the imposition of fines, penalties or judgments against us or significant limitations on our activities. In addition, the regulatory environment in which we operate is subject to change. New or revised requirements imposed by governmental authorities could have adverse effects on us, including increased costs of compliance. Changes in the regulation of our operations or changes in interpretations of existing regulations by courts or regulators or our inability to comply with current or future regulations could adversely affect us by reducing our revenues, increasing our operating expenses and exposing us to significant liabilities. Our business involves risks of liability associated with the Health and Pet industries, which could adversely affect our business, financial condition or results of operations. As such, we may face potential liability for any of:

	defamation;
	invasion of privacy;
	copyright infringement;
	actions for royalties and accountings;
	trademark misappropriation;
	trade secret misappropriation;
	breach of contract;
	negligence; and/or
	other claims based on the nature and content of the materials distributed.

These types of claims have been brought, sometimes successfully, against merchandisers, online services and other manufacturers, developers and distributors of ~~health~~vehicle ~~and~~parts ~~pet~~ related products. We could also be exposed to liability in connection with material available through our Internet sites. We currently do not have limited liability insurance and have no current plans to obtain such insurance which could have a material adverse effect on us.

Our products have not been approved by the FDA nor have we applied for approval. The FDA may classify our pain relief products as a drug specifically because in our efforts to market or sell our pain relief product we state here and elsewhere that our pain relief product may be used as a pain relief product in the pet industry. If in fact our product was considered a "drug" under section 201(g) of the Act, the FDA (Food and Drug Administration) could seek to take enforcement action against us if we were deemed to be marketing an unapproved new animal drug. In addition if our product was considered a "drug" under section 201(g) of the Act the FDA it could be deemed to be a "new animal drug," as defined under section 201(v) of the Act because it may not be generally recognized among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. If our product were deemed to be a "new animal drug," as defined under section 201(v) of the Act, to be legally marketed as a new animal drug we must have an approved new animal drug application, conditionally approved new animal drug application, or index listing under sections 512, 571, and 572 of the Act. We have not applied for an animal drug application with the FDA. We have no intention to apply to the FDA for approval for our pain relief product.

If our product was found to be a "drug" under section 201(g) of the Act the FDA (Food and Drug Administration) we would be forced to stop any production and sales of the product which could adversely affect our business, financial condition or results of operations. Further we may face potential liability for selling our product as a "drug". Further if we were found to be marketing an unapproved drug by the FDA we could potentially face FDA enforcement action. (See: Risk Factors on Page 10).

Intellectual Property & Proprietary Rights

WeThe ~~regard~~Company ~~substantial~~owns ~~elements~~the ofworldwide ~~our~~licensing ~~businesses~~rights ~~and~~for ~~website~~the asOptimized ~~proprietary~~Fuel ~~and~~Maximizer weproduct ~~shall~~line. ~~attempt~~The tomanufacturer ~~protect~~of ~~them~~the byOptimized ~~relying~~Fuel onmaximizer ~~copyright,~~is ~~trademark,~~Optimized ~~service~~Fuel ~~mark~~Technologies. ~~and~~Optimized ~~trade~~fuel ~~secret~~Technologies ~~laws,~~owns ~~restrictions~~the onintellectual ~~disclosure~~property and ~~transferring~~patent ~~title~~for ~~and~~the ~~other~~Optimized ~~methods.~~Fuel ToMaximizer, ~~date~~and wehas ~~have~~been noissued ~~copyrights~~the orUnited ~~trademarks~~States ~~that~~patent ~~have~~for ~~been~~the ~~applied for~~product. WeIn doaddition, ~~not~~they ~~believe~~have ~~that~~filed ~~our~~and ~~Green~~continue ~~Meadow~~to PRfile ~~formula~~for orinternational ~~the~~patent ~~PawPal~~protection ~~is patentable and therefore will not expend capital~~ in ~~attempting~~various tocountries ~~patent~~around the ~~products~~world. ~~However~~Per weAgreement, ~~will attempt to trademark~~ the ~~name~~Company ~~PawPal;~~will ~~but as yet have~~ not ~~done~~market sothe ~~and~~Fuel doMaximizer ~~not~~product ~~know~~in ~~whether~~any ~~once~~country ~~the~~unless ~~trademark~~there is ~~applied~~patent ~~for,~~and ~~that~~intellectual itproperty ~~would be granted~~protection. ~~Without~~We ~~patent~~regard orsubstantial ~~trademark~~elements ~~protection~~of itour isbusinesses ~~possible~~as ~~that~~proprietary ~~our formula~~ and ~~PawPal~~we ~~products~~shall ~~could~~attempt beto ~~duplicated~~protect them by arelying ~~Company~~on ~~with~~copyright, ~~greater~~trademark, ~~resources~~service ~~that~~mark ~~us;~~and ~~which~~trade insecret ~~turn~~laws, ~~could~~restrictions ~~take~~on ~~away~~disclosure ~~from~~and ~~any~~transferring ~~current~~title ~~market~~and ~~share~~other ~~or any market share that we may create in the future~~methods.

~~Optec~~On ~~Devices~~August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optimized Fuel Maximizer on a manufacturer direct basis. As the Company owns the exclusive licensing rights to sales of the Optimized Fuel Maximizer; per the Royalty agreement dated August 27, 2018 the Company agreed to the acceptance of royalty revenue generated by sales which are made on a manufacturer direct basis.

Sale and Marketing

We acquired seven Optec Fuel Maximizer devices for vehicles from OPTEC Optimized Fuel Technologies, one of our suppliers, in March of 2017 for testing; comprised of 2 HD Optec Fuel Maximizers, 2 Intermediate Optec Fuel Maximizers, 1 Optec Fuel Maximizer for gas passenger cars, 1 Optec Fuel Maximizer for diesel passenger cars. The Optec Fuel Maximizer is an on demand technology designed for computer controlled gasoline and diesel engines for improved fuel efficiency while simultaneously reducing harmful emissions. We believe that the technology can reduce greenhouse gas emissions which in turn could conceivably aid in making the air much healthier in our cities. Should the Company’s testing of the devices prove to meet the claims of the manufacturer we may enter into future discussions with Optec for potential licensing rights for the devices. (For further information on Optec Products acquired-www.optecmpg.com)

Currently, we have sold the devices acquired from OPTEC to Autovative Technologies, Inc. at a reduced price in order to obtain their testing results for the products so that we might better understand more precisely the benefits and effects of using the OPTEC devices. We anticipate making a determination of how we will proceed with the OPTEC devices in the first quarter of 2017.

Employees

We are a new, developing company and currently have only ~~two~~one ~~part-~~full time employees, Peter ~~Sallonne~~Sollenne our ~~president and~~ CEO ~~and Stanley Windhorn our Secretary. We entered into an agreement on January 15~~, ~~2015 with~~CFO, ~~Stanley~~board ~~Windhorn,~~Member for a salary to be paid in the amount of $2,000 per month. For the three months ended March 31, 2015, $6,000 was paid to Mr. Windhorn per the agreement. Subsequently, we determined that the revenues generated by the Company were not sufficient to support operations and ~~a salary~~Secretary. We entered into a new employment agreement on April 1, 2015 which supersedes any past agreements whereby Stanley Windhorn under the new agreement will be awarded compensation at the discretion of the Company’s board. The Company has not incurred any salary under this new agreement since April 1, 2015 to the date of the issuance of this Form 10K.

117

ITEM 1A. RISK FACTORS

As a smaller reporting company, we are not required to provide the information required by this section.

ITEM 2. DESCRIPTION OF PROPERTY CORPORATE INFORMATION

CORPORATE INFORMATION

Office and Facilities

The Company currently ~~utilizes~~has ~~space~~an ~~provided~~office by& ~~its~~warehouse ~~President,~~lease ~~Peter~~agreement ~~Sollenne,~~for atspace nolocated ~~charge~~at to2721 ~~the~~West ~~Company.~~Loker ~~Our mailing address is 2173 Salk~~ Avenue, ~~Suite 250,~~ Carlsbad, CA ~~92008~~92010. Our telephone number at that address is (760) ~~456~~444-~~5777~~5566. On May 1, 2018 the Company entered an office lease to sublet warehouse and office space from Optimized Fuel Technologies, a related party. The term of the lease is for 13 months at a monthly rent of $2,500 per month.

WEBSITE POSTING OF SEC FILINGS

Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to such reports are available, free of charge, on our website and can be accessed on the SEC's Edgar database. Further, a copy of this annual report on Form 10-K is located at the SEC's Public Reference Room at 100 F Street, NE, Washington, D. C. 20549. Information on the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding our filings at www.sec.gov.

Bankruptcy or Receivership or Similar Proceedings

None.

ITEM 3. LEGAL PROCEEDINGS

We were not subject to any legal proceedings during the twelve months ended June 30, ~~2017~~2018 or ~~2016~~2017 and none are threatened or pending to the best of our knowledge or belief.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable to our Company.

128

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER REPURCHASES OF EQUITY SECURITIES

Only a limited market exists for our securities. There is no assurance that a regular trading market will develop, or if developed, that it will be sustained. Therefore, a shareholder in all likelihood will be unable to resell his securities in our company. Furthermore, it is unlikely that a lending institution will accept our securities as pledged collateral for loans unless a regular trading market develops.

Our company’s securities are traded on the ~~world’s largest electronic interdealer quotation system~~ “OTCQB” operated by the OTC Markets Group under the symbol “~~GRMD~~OPTI”.

Year Ended June 30, 2017*	High Bid		Low Bid
FISCAL YEAR 2018
2017
First Quarter	$	3.10	$	3.05
Year ended June 30, 2017	$	3.00	$	0.20
Second Quarter		4.55		3.90
Third Quarter		4.20		3.60
Fourth Quarter		6.49		4.03
FISCAL YEAR 2017
First Quarter	$	.30	$	.20
Second Quarter		4.50		4.40
Third Quarter		1.00		.85
Fourth Quarter		2.00		1.51

As of June 30, ~~2017~~2018, we had 5217,~~944~~829,~~500~~947 shares of our common stock outstanding ~~(as restated for the 7 for 1 forward split of the Company's common stock effective June 1, 2015)~~ and the number of stockholders of record of our common stock was 42.

DIVIDENDS

We have never declared or paid any cash dividends on our common stock.

RECENT SALES OF UNREGISTERED SECURITIES

~~None~~In the year ended June 30, 2018, 85,000 unregistered shares were sold through a private placement memorandum. The shares were sold at $2.00 per share to four shareholders.

PURCHASES OF EQUITY SECURITIES BY THE REGISTRANT AND AFFILIATED PURCHASERS

None.

ITEM 6. SELECTED FINANCIAL DATA

Not applicable to a "smaller reporting company" as defined in Item 10(f)(1) of SEC Regulation S-K.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

GENERAL

This Management's Discussion and Analysis or Plan of Operation contains forward-looking statements that involve future events, our future performance and our expected future operations and actions. In some cases, you can identify forward-looking statements by the use of words such as "may", "will", "should", "anticipate", "believe", "expect", "plan", "future", "intend", "could", "estimate", "predict", "hope", "potential", "continue", or the negative of these terms or other similar expressions. These forward-looking statements are only our predictions and involve numerous assumptions, risks and uncertainties. Our actual results or actions may differ materially from these forward-looking statements for many reasons, including, but not limited to, the matters discussed in this report under the caption "Risk Factors". We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus. We undertake no obligation to publicly update any forward looking-statements, whether as a result of new information, future events or otherwise.

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included in this report.

The following table provides selected financial data about us for the fiscal years ended June 30, ~~2017~~2018 and ~~2016~~2017. For detailed financial information, see the audited Financial Statements included in this report.

	Year End June 30			Year End June 30
	2017			2016
	2018			2017
Balance Sheet Data:
Cash	$	~~342~~30,799		$	~~8,977~~342
Total assets	$	17626,~~688~~369		$	2517,~~699~~688
Total liabilities	$	71,~~000~~769,055		$	57,000
Retained earnings (accumulated deficit)	$	(42,762	)		(32,751	)
Total stockholder’s equity (deficit)	$	(1,142,696	)	$	10,688	)
Operating Data:
Revenue	$	2491,~~200~~105		$	3024,~~875~~200
Cost of revenue	$	758,~~000~~360		$	127,000
Operating expenses	$	27204,~~211~~328		$	5127,~~806~~211
Income tax expense (benefit)	$	-			-
Other Expense	$	1,149,291		$	-
Net income (loss)	$	(101,~~011~~320,874	)	$	(3210,~~931~~011	)

Optec International, Inc. (Formerly Green Meadow Products, Inc. "the Company", "~~GMP", "~~we", "us" or "our") was incorporated under the laws of the State of Wyoming on June 22, 2012.

The Company’s goal from the outset was to establish itself as a “Green” Company where our focus would be on products that were environmentally friendly. WeThe ~~have~~Company ~~developed~~currently distributes products ~~for~~which are “environmentally friendly”. In the ~~pet~~last ~~natural~~year ~~health~~the ~~supplement~~Company ~~and~~has ~~related~~focused ~~fields;~~its ~~with~~resources atowards ~~focus~~the sales of The Optimized Fuel Maximizer, an on ~~natural~~demand ~~pet~~technology ~~pain~~designed ~~relief~~for ~~formulas~~computer controlled gasoline and ~~pet~~diesel ~~pain~~engines ~~preventative~~for ~~products~~improved fuel efficiency and performance while simultaneously reducing harmful emissions. We believe that the technology can reduce greenhouse gas emissions which in turn could conceivably aid in making the air much healthier in our cities. (For further information on Optec Products acquired-www.optecmpg.com).

Our current focus is on the sales of licensing rights to our Green Meadow PR formula and the manufacturing and sales of our Green Meadow PR formula, both of which are organic products, as well as the manufacturing and sales of our PawPal product and our recently acquired stress relief formula. We have also tested and sold organic dog treats which contain our pain relief formula and are currently seeking funding sources for the manufacturing of the dog treats. We believe it will be able to successfully compete in today's natural supplement and related fields industry by controlling production costs and by limiting its distribution expenses using, primarily, online marketing tools to promote its products and to further develop its digital strategies.10

WePlan ~~are~~of ~~currently seeking funding for our pain relief product for dogs as well as our dog treats which contain our pain relief formula.~~Operation

InOur ~~the~~future ~~three~~plan ~~months~~is ~~ended~~to ~~March~~expand ~~31,~~our ~~2017,~~sales we& ~~reviewed additional potential products for~~ marketing ~~and~~of ~~distribution in what we consider to be~~ the ~~“Green~~Optimized ~~Sector” or “environmentally friendly”. As a result, we acquired seven Optec~~ Fuel Maximizer, ~~devices~~concentrating ~~for~~primarily ~~vehicles~~ in ~~March~~the ofNorth ~~2017~~America ~~for testing; comprised of 2 HD Optec Fuel Maximizers~~region, 2and ~~Intermediate~~followed ~~Optec~~up ~~Fuel~~by ~~Maximizers,~~expansion 1into ~~Optec~~other ~~Fuel~~geographic ~~Maximizer~~areas ~~for~~subsequent ~~gas~~to ~~passenger~~locating ~~cars, 1 Optec Fuel Maximizer for diesel passenger cars. The Optec Fuel Maximizer is an on demand technology designed for computer controlled gasoline~~ and ~~diesel~~contracting ~~engines~~with ~~for~~large ~~improved~~distributors ~~fuel efficiency while simultaneously reducing harmful emissions. We believe~~ that ~~the~~already ~~technology~~operate ~~can reduce greenhouse gas emissions which~~ in ~~turn could conceivably aid in making~~ the ~~air~~automotive ~~much~~aftermarket ~~healthier in our cities~~arena. ~~Should~~We ~~the~~will ~~Company’s~~also ~~testing~~continue ofto ~~the~~work ~~devices~~closely ~~prove~~with toand ~~meet~~support the ~~claims of the~~ manufacturer weto ~~may~~obtain ~~enter~~additional ~~into~~certifications ~~future~~from ~~discussions~~the ~~with~~California ~~Optec~~Air ~~for~~Resources ~~potential~~Board ~~licensing~~(CARB). ~~rights~~Currently ~~for~~there ~~the~~are ~~devices.~~two (~~For~~2) ~~further~~major ~~information~~tests onin ~~Optec Products acquired-www~~progress.~~optecmpg.com)~~

14Marketing and Sales efforts:

Successful implementation of our business strategy depends on factors specific to the further development of our products, additional financing through equity or debt sources and numerous other factors that may be beyond our control. Adverse changes in the following factors could undermine our business strategy and have a material adverse effect on our business, financial condition, and results of operations and cash flow:

-the competitive environment in the aftermarket automotive parts sector that may force us to reduce prices below the optimal desired pricing level or increase promotional spending;

-the ability to anticipate changes in consumer preferences and to meet customers' needs for trading products in a timely cost effective manner; and

-the ability to establish, maintain and eventually grow market share in a competitive environment.

Significant Accounting Policies and Estimates

Management's Discussion and Analysis of Financial Condition and Results of Operations discusses the Company's consolidated financial statements which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experiences and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Other Intangible Assets

Intangible assets other than goodwill primarily represent acquired intangible assets including licenses, patent costs, acquired technology, internally developed technology, customer relationships, non-compete agreements, trade names and trademarks. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful life, which is determined by identifying the period over which most of the cash flows are expected to be generated.

For intangibles with finite lives, we review the carrying amounts for potential impairment when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Examples of such a change in circumstances include a significant decrease in selling price, a significant adverse change in the extent or manner in which an asset is being used or a significant adverse change in the legal or business climate. In evaluating recoverability, we group assets and liabilities at the lowest level such that the identifiable cash flows relating to the group are largely independent of the cash flows of other assets and liabilities. We then compare the carrying amounts of the assets or asset groups with the related estimated undiscounted future cash flows. In the event impairment exists, an impairment charge is recorded as the amount by which the carrying amount of the asset or asset group exceeds the fair value. Fair value is determined by reference to estimated selling values of assets in similar condition or by using a discounted cash flow model. In addition, the remaining amortization period for the impaired asset would be reassessed and, if necessary, revised.

No impairment charges for intangible assets with finite lives were recorded for the years ended June 30, 2018 and 2017.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification No. 605, "Revenue Recognition" ("ASC-605") ASC-605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

The Company's revenues have been generated primarily through the sales of our Optimized Fuel Maximizer and sublicense and distribution agreements related to our PawPal product and our pain relief products. The terms of these agreements generally consist solely of upfront, nonrefundable payments for licensing and distribution rights. Revenues from non-refundable licensing and distribution fees are recognized upon receipt of the payment if the license has stand-alone value and we do not have ongoing involvement or obligations.

For the year ended June 30, ~~2016~~2018 ~~and~~terms of sales of the optimized fuel maximizer consisted of sales with extended terms for payment, however revenue was recorded upon the invoice being sent with products that was shipped. For the year ended June 30, 2017, all license payments met the above criteria or in the case of one contract, the only continuing involvement was to sell our products to the distributor at pricing that is consistent with market transactions, thereby allowing for the recognition of revenue for the licensing and distribution arrangements upon receipt.

When non-refundable license fees do not meet this criteria, the license revenues are recognized over the expected period of performance. We periodically review for any expected period of substantial involvement under the agreements that provide for non-refundable up-front payments and license fees. If ever applicable, we will adjust the amortization periods when appropriate to reflect changes in assumptions relating to the duration of our expected involvement.

In the years ended June 30, ~~2016 and~~ 2017, we also engaged in a marketing test of various dog treats formulated by us, through street fair venues. We recognized revenue upon receipt from sales.

In March of 2016, we were hired as a consultant by Collective Media to aid in the production of a video relating to pain relief products and dogs. Revenue was recognized upon the completion of our consulting. Services.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires us to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.

1512

Results of Operations

For ~~The~~the Year Ended June 30, ~~2017~~2018 Compared Toto ~~The~~the Year Ended June 30, ~~2016~~2017.

Revenue

For the year ended June 30, ~~2017~~2018, we recognized revenues of $2491,~~200~~105 compared with $3024,~~875~~200 of revenue for the year ended June 30, ~~2016~~2017. During the year ended June 30, ~~2017~~2018, we recognized $1285,~~000~~100 in sales of the Optec devices ~~to Autovative Technologies, Inc.,~~ and $124,~~200~~500 ~~from~~in the sale of a sub license agreements of our Green Meadow PR formula ~~which included~~ and $71,~~100~~505 in other sales ~~of sub licensing rights to Sandstone Enterprises and $5,100 of sublicensing rights to Mountain High,~~ compared to year ended June 30, ~~2016~~2017, where we recognized $912,~~875~~000 in sales of ~~Petaprin,~~ the ~~pain~~Optec ~~relief~~devices ~~product for dogs~~ and $1512,~~000~~200 infrom ~~which~~the ~~there~~sale ~~were~~of ~~licensing~~sub ~~and~~license ~~distribution~~agreements ~~rights~~of ~~for~~ our Green Meadow PR formula ~~for dogs~~. This included $10,000 in sales of sub licensing rights to Mountain High Products, Inc., $5,000 in sales of sub-licensing rights to Wholesale 4 You, Inc. and a commercial video consulting service of $6,000 from Collective Media.

Cost of Sales

For the year ended June 30, ~~2017~~2018, we recognized cost of goods of $758,~~000~~360 relating to the Optec product which we sold for $1285,~~000~~100 in the period, compared to year ended June 30, ~~2016~~2017, ~~where~~ we recognized cost of goods ~~sold~~ of $7,000 relating to the ~~dog~~Optec ~~treats~~product which we sold for $912,~~875~~000 in the period ~~and the assistance in video production for $5~~,~~000. The increase in cost of goods was attributable to the cost of manufacturing of the dog treats and the video which was produced during the year.~~

Gross Profit

For the year ended June 30, ~~2017~~2018, we recognized a gross profit of $1732,~~200~~745 compared with ~~a gross profit of $18,875 for~~ the year ended June 30, ~~2016~~2017, we recognized a ~~decrease~~gross profit of $117,~~675~~200. The ~~decrease~~increase in gross profits is due to aan ~~decrease~~increase in ~~sales~~Optec ofProduct ~~licensing~~sales ~~agreements~~ for the year end June 30, ~~2017 and an increase in costs~~2018.

Operating Expenses

For the year ended June 30, ~~2017~~2018, we incurred total operating expenses of $27204,~~211~~328 ~~before~~other ~~tax~~expenses ~~compared~~incurred ~~to $51,806~~ for the ~~year~~twelve-month period ended June 30, ~~2016~~2018 ~~with~~included a ~~decrease~~change ofin ~~$24,595~~fair asvalue ~~a result~~ of ~~decreased~~derivative ~~expenses~~liabilities ~~with~~of ~~regard~~$769,394 toand ~~the~~interest ~~Company’s~~on ~~expenses~~convertible ~~for~~notes ~~being public Company. During the twelve months ended June 30~~$379,897 ~~2017,~~for wea ~~incurred~~total ~~professional~~expense ~~fees~~ of $161,~~486~~353,619 ~~which~~compared ~~were attributable~~ to ~~expenses~~the ~~relating~~year toended ~~our~~June ~~SEC filings and accounting costs~~30, ~~amortization~~2017 ofwe ~~$4,076,~~incurred ~~advertising~~total ~~and~~operating ~~marketing~~ expenses of $527,~~075,~~211 ~~consulting~~before ~~fees of $1,500 and general and administrative costs of $74~~tax. ByIncreases ~~comparison,~~in ~~during~~expenses for the year ~~end~~ended June 30, ~~2016,~~2018 ~~our~~is ~~operating~~attributable ~~expenses~~to ~~comprised marketing expense of $6,000 for promotional~~ costs associated with the sales of ~~our~~the ~~Green~~Optimized ~~Meadow~~Fuel PRMaximizer ~~formula,~~units ~~licensing rights~~ and ~~Petaprin~~the ~~product,~~costs ~~amortization~~associated ofwith ~~$4,076~~three ~~and~~convertible ~~professional~~notes ~~fees~~which ofthe ~~$29,825,~~Company ~~and consulting fees of $11,000 and General and administrative expense of $905~~issued.

~~Income~~During ~~Tax~~the year ended June 30, 2018, we incurred professional fees of $37,276 which were attributable to expenses relating to our SEC filings and accounting costs, formula amortization of $3,326 and web site amortization of $4,250, advertising and marketing expenses of $7,745, consulting fees of $55,255, bad debt expense of $85,100, commission of $5,000, rent expense of $5,000, general and administrative costs of $1,376 by comparison to the year ended June 30, 2017, where we incurred professional fees of $16,486 which were attributable to expenses relating to our SEC filings and accounting costs, amortization of $4,076, advertising and marketing expenses of $5,075, consulting fees of $1,500 and general and administrative costs of $74.

During the years ended June 30, 2017 and 2016, we recognized no tax credit.

Net Income (Loss)

During the year ended June 30, ~~2017~~2018, we incurred a net loss of $101,~~011~~320,874 compared to a net loss of $3210,~~931~~011 during the year ended June 30, ~~2016~~2017 due to the factors discussed above.

1613

Liquidity and Capital Resources

For Year Ended June 30, ~~2017~~2018 Compared Toto Year Ended June 30, ~~2016.~~2017

As of June 30, ~~2017~~2018, the Company had cash on hand of $~~342~~30,799, total assets of $17626,~~688~~369, total liabilities of $71,~~000~~769,055 and stockholders' equity (deficit) of $10(1,~~688~~142,686) compared to June 30, ~~2016, when~~ 2017 the Company had cash on hand of $8342,~~977,~~ total assets of $2517,~~699~~688, total liabilities of $57,000 and stockholders' equity of $2010,~~699~~688. The change in shareholders' equity at the year ended June 30, 2018 was largely attributable to operating losses incurred in the period and non-cash issuance of common stock for licensing rights.

The change in shareholders' equity at the year ended June 30, 2017 was largely attributable to operating losses incurred in the period.

Operating Activities

During the year ended June 30, ~~2017~~2018, we used $8281,~~635~~810 cash in operating activities compared to $248,~~185~~635 cash used in operating activities during the year ended June 30, ~~2016~~2017. During the year ended June 30, ~~2017~~2018, we incurred a loss of $101,~~011~~320,874 of which $47,~~076~~576 related to noncash amortization, amortization of debt discount of $276,413, bad debt of $85,100, changes in fair value of derivative liability of $769,394 increased our balance of accounts payable by $253,760, decrease in accounts receivable by $80,400, decrease to cash for inventory by $85,000, ~~and~~decrease ~~reduced~~to ~~the~~cash ~~balance~~for ~~Accounts~~prepaid ~~Receivable~~salary by $43,~~700~~000, increased accrued interest by $3,221, and increase in stock issued for services $12,000. By comparison during the year ended June 30, ~~2016~~2017, we incurred a loss of $3210,~~931~~011, of which $4,076 related to noncash amortization ~~expense~~, ~~decreased~~increase ~~our~~in ~~income~~accounts ~~tax~~ payable by $322,000 and ~~increased~~an ~~our~~increase ~~balance~~in of accounts ~~payable~~receivable by $4,~~702~~700.

Investing Activities

For the year ended June 30, ~~2015~~2018, we ~~invested~~used $5109,000 ~~towards~~cash ~~the~~in ~~continued~~investing ~~development~~activities ofby ~~our~~increased ~~website~~notes ~~and~~receivables ~~the~~to ~~purchase~~Optimized ofFuel ~~intellectual~~Technologies, ~~property~~a ~~consisting~~related ofparty. The note receivable was later reduced in a ~~formula~~non-cash ~~for~~transaction ~~stress~~to offset ~~relief~~a ~~for~~note ~~dogs~~payable ~~for~~to ~~$250~~Optimized Fuel Technologies, a related party. There has been no cash generated from or used in investing activities during the year ended June 30, 2017.

Financing Activities

During the ~~years~~year ended June 30, ~~2017~~2018 we had proceeds from issuance of notes payable for $482,000, loan from related party of $100, proceeds from sale of capital stock of $170,000, Stock offering costs of $17,000 and ~~2016~~principal payments on debt of $213,833. During the year ended 2017, we neither generated nor used any funds in financing activities.

~~Our~~The ~~auditor's~~financial ~~report~~statements ~~states~~have been prepared on a going concern basis which assumes the ~~following~~Company ~~with~~will ~~regard~~be able to ~~our~~realize ~~ability~~its toassets ~~continue~~and asdischarge aits ~~going~~liabilities ~~concern~~in the normal course of business for the foreseeable future. As at June 30, ~~"has~~2018, the Company had yet to establish a proven, reliable, ~~consistent~~recurring ~~and proven~~ source of revenue to ~~meet~~fund its ongoing operating costs ~~on an ongoing basis~~ and ~~currently~~with ~~does~~insufficient ~~not~~funds ~~have sufficient available funding~~ to fully implement its proposed business plan. ~~These~~This ~~factors~~raises ~~raise~~ substantial doubt about ~~its~~the Company's ability to continue as a going concern".

The ~~Company~~ability ~~believes~~of itthe ~~may~~Company ~~have~~to ~~sufficient~~continue ~~cash~~as ~~resources~~a ~~available~~going toconcern ~~fund~~is ~~its~~dependent ~~primary~~on ~~operation for~~ the ~~next~~Company ~~twelve~~obtaining ~~(12)~~adequate ~~months~~capital ~~but~~to ~~does~~fund ~~not~~operating ~~have~~losses ~~the~~until ~~funding~~it tobecomes ~~fully implement its business plan~~profitable. ~~The~~If the Company ~~has~~is nounable ~~agreements~~to inobtain ~~place~~adequate ~~with its shareholders~~capital, ~~officer~~it ~~and~~could ~~director~~be orforced ~~with any third parties~~ to ~~fund~~cease operations. ~~The Company has not negotiated nor has available to it any other third party sources of liquidity.~~

In order to continue as a going concern, the Company will need, among other things, additional capital resources. The Company is currently conducting an offering of its debt or equity securities to obtain additional operating capital. The Company is dependent upon its ability, and will continue to attempt, to secure equity and/or debt financing. There are no assurances that the Company will be successful and without sufficient financing it would be unlikely for the Company to continue as a going concern.

The Company has no current off balance sheet arrangements and does not anticipate entering into any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition.

Related parties

We entered into an agreement ~~on January 15, 2015~~ with our ~~former~~ President, ~~Stanley~~Peter ~~Windhorn~~Sollenne, for a salary to be paid in the amount of $23,000 per month. For the three months ended March 31, 2015, $6,000 was paid to Mr. Windhorn per the agreement. Subsequently we determined that the revenues generated by the Company were not sufficient to support operations and a salary. We entered into a new employment agreement on April 1, 2015 which supersedes any past agreements whereby Stanley Windhorn under the new agreement will be awarded compensation at the discretion of the Company’s board. The Company has not incurred any salary under this new agreement since April 1, 2015 through the date of the issuance of this Form 10K.

17On June 4, 2018 the Company entered into an Exclusive Licensing Agreement with Optimized Fuel Technologies for the right to exclusively distribute and sell the Optimized Fuel Maximizer internationally, with the exception of the United States and Canada. Consideration of $501,500 was paid for the licensing right in the form of one million five hundred thousand (1,500,000) shares of the Company’s common shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies; in addition to five hundred thousand dollars ($500,000) to be paid over the course of 24 months from the date herein; of which the Company has paid $109,000.

~~Plan~~On June 20, 2018 the Company entered into an Exclusive Licensing Agreement Addendum with Optimized Fuel Technologies for the right to exclusively sell the Optimized Fuel Maximizer worldwide. On June 4, 2018, the Company had entered into an Exclusive Licensing Agreement with Optimized Fuel Technologies for the right to exclusively sell the Optimized Fuel Maximizer internationally, with the exception of ~~Operation~~the United States and Canada; this agreement extends exclusive marketing right to include North America and Canada. Consideration of $1,000 was paid for the licensing rights under the addendum in the form of one million (1,000,000) shares of the Company’s common shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies.

~~Product~~On ~~Development~~ August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optimized Fuel Maximizer on a manufacturer direct basis. As the Company owns the exclusive licensing rights to sales of the Optimized Fuel Maximizer; per the Royalty agreement dated August 27, 2018 the Company agreed to the acceptance of royalty revenue generated by sales which are made on a manufacturer direct basis.

~~Our~~On ~~future~~May ~~plan~~1, is2018 ~~to research~~ the ~~incorporation~~Company ofentered ~~our~~an ~~Green~~office ~~Meadow~~lease PRto ~~formula~~sublet warehouse and ~~our~~office ~~stress~~space ~~relief~~from ~~formula~~Optimized ~~for~~Fuel ~~dogs~~Technologies, ~~into~~ a ~~bite~~related ~~size bar which would have a flavor appealing to dogs~~party. The ~~bar~~term ~~will be like a “treat” for dogs. We are also researching the incorporation~~ of ~~a flavor into~~ the ~~pain~~lease ~~relief tablets and stress relief tablets that dogs would find appealing to eat. We have found that our current pain relief product~~ is ~~typically~~for ~~broken~~13 upmonths ~~into~~at a ~~dog’s~~monthly ~~food~~rent ~~as dogs do not generally like the taste~~ of ~~the~~$2,500 ~~tablet~~per ~~without food~~month. ~~Thus the ongoing research into finding an optimum way in which a flavor could be incorporated into a bar and tablet appealing to dogs.~~

Cost for research and development of the Green Meadow PR formula and stress relief formula into bars or flavored tablets have not yet been determined. We believe that we will have to raise additional capital either through debt or equity financing in order to accomplish our goals. As of June 30, 2017, we have not yet discussed financing with any source for either debt or equity financing.

We are also considering the acquisition or the possibility of a joint venture with a Company with other “green” (green meaning environmentally friendly) products both within the pet industry and outside of the pet industry. As we have limited capital any acquisitions would possibly be done through the use of our common stock or possibly through a preferred class of stock (which has of this date not been approved or created by the board of Directors). At the year ended June 30, 2017, we have not entered into any negotiations or letter of intents with and targeted acquisitions or joint venture prospects.

Marketing and Sales efforts:

Our marketing efforts will primarily be related to seeking optimum methods for selling our bars and tablets once the flavors are optimized for the bars.

We plan on optimizing Search Engine Optimization ("SEO") work and internet marketing, and subsequently believe sales will be initially supported through our website. We also plan on engaging a call center for developing interest in our products by pet stores and veterinarians. We have not yet begun either stage of marketing. We believe that once our bars are finalized for the Green Meadow PR formula and stress relief formula and\or our flavored tablets are finalized we will be in a position to launch our marketing campaign. We also believe that we will need to initially seek equity or debt financing to accomplish our marketing goals.

Successful implementation of our business strategy depends on factors specific to the further development of our products, regulations regarding equities trading, additional financing through equity or debt sources and numerous other factors that may be beyond our control. Adverse changes in the following factors could undermine our business strategy and have a material adverse effect on our business, financial condition, and results of operations and cash flow:

-the competitive environment in the pet sector that may force us to reduce prices below the optimal desired pricing level or increase promotional spending;

-the ability to anticipate changes in consumer preferences and to meet customers' needs for trading products in a timely cost effective manner; and

-the ability to establish, maintain and eventually grow market share in a competitive environment.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

1815

~~ITEM 8.~~ FINANCIAL STATEMENTS ITEM 8

AUDITED FINANCIAL STATEMENTS

OPTEC INTERNATIONAL, INC

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

TABLE OF CONTENTS

For the Years Ended June 30, ~~2017~~2018 and ~~2016~~2017

Reports of Registered Independent Accounting Firms	21
Reports of Registered Independent Accounting Firm	F-2
Financial Statements
Balance Sheet as of June 30, 2017 and 2016	22
Balance Sheets as of June 30, 2018 and 2017	F-4
Statements of Operations for the years ended June 30, 2017 and 2016	23
Statements of Operations for the years ended June 30, 2018 and 2017	F-5
Statements of Changes in Stockholders' Equity for years ended June 30, 2017 and 2016	24
Statements of Changes in Stockholders' Equity for years ended June 30, 2018 and 2017	F-6
Statements of Cash Flows for years ended June 30, 2017 and 2016	25
Statements of Cash Flows for years ended June 30, 2018 and 2017	F-7
Notes to the Audited Financial Statements	26F-8

19F-1

Pritchett, Siler & Hardy, P.C.

Certified Public Accountants

1438 N Highway 89, Suite 130

Farmington, UT 84025

Office: (801)447-9572 Fax: (801)447-9578

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of Optec International, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Optec International, Inc. (the Company) as of June 30, 2018 and the related statements of operations, stockholders’ equity, and cash flows for the year then ended, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2018, and the results of its operations and its cash flows for the year ended June 30, 2018, in conformity with accounting principles generally accepted in the United States of America.

Consideration of the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has incurred losses since inception, has negative cash flows from operations, and has negative working capital. These factors raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 3 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Haynie & Company

We have served as the Company’s auditor since 2018

Salt Lake City, Utah

October 12, 2018

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

Optec International, Inc.

~~2173~~2721 ~~Salk~~Loker Avenue~~, Suite 250,~~

~~Carlsbad~~WestCarlsbad, CA ~~92008~~92010

We have audited the accompanying balance ~~sheets~~sheet of Optec International, Inc.(formerly, Green Meadows Products, Inc.) as of June 30, 2017 and ~~2016 and~~ the related statements of operations, changes in stockholders’ equity and cash flows for the ~~years~~year then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our ~~audits~~audit.

We conducted our ~~audits~~audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit ~~provide~~provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Optec International, Inc. as of June 30, 2017 and ~~2016 and~~ the results of its operations and its cash flows for the ~~years~~year then ended in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has suffered continuing losses and has yet to establish a reliable, consistent and proven source of revenue to meet its operating costs on an ongoing basis and currently does not have sufficient available funding to fully implement its business plan. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Pritchett, Siler & Hardy, P.C.

Pritchett, Siler & Hardy, P.C.

~~Farmington~~Salt Lake City, Utah

September 26, 2017

20F-3

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

BALANCE SHEETS

	June 30, 2017			June 30, 2016
	June 30, 2018			June 30, 2017
Assets
Current Assets
Cash	$	~~342~~30,799		$	~~8,977~~342
Accounts Receivable		4,700			-
Accounts receivable net of allowance for doubtful accounts		-			4,700
Total Current Assets		5,042			8,977
Prepaid Salary-related party		3,000			-
Inventory		85,000			-
Total Current Assets		118,799			5,042
Other Assets
Web development costs, net of accumulated amortization of $8,500 and $5,500 respectively.		6,500			9,500
License		502,500			-
Other intangible assets, net of accumulated amortization of $4,604 and $3,528 respectively.		6,146			7,222
Web development costs, and other intangible assets net of accumulated amortization of $20,600 and $3,104 respectively		5,070			12,646
Total Assets		17,688		$	25,699
Total Other Assets		507,570			12,646
Liabilities And Stockholders' Equity
Total Assets	$	626,369		$	17,688
Liabilities and Stockholders' Equity (Deficit)
Current Liabilities
Accounts payable	$	7,000		$	5,000
Accounts payable and accrued expenses-related party		60,760			7,000
Total Current Liabilities		7,000			5,000
Accrued expenses-related party		-			-
Total Liabilities		7,000			5,000
Derivative liability		1,265,394			-
Accrued Interest		3,221			-
Notes Payable net of discount		48,580			-
Notes Payable-related party		391,000			-
Loan from related party		100			-
Total Current Liabilities	$	1,769,055		$	7,000
Total Liabilities		1,769,055			7,000
Commitments and Contingencies		-			-
Stockholders' Equity
Stockholders' Equity (Deficit)
Common stock $0.001 par value 75,000,000 shares authorized 52,944,500 shares issued and outstanding		52,945			52,945
Common stock $0.001 par value 75,000,000 shares authorized 17,829,947 and 52,944,500 shares issued and outstanding at June 30, 2018 and June 30, 2017, respectively		17,830			52,945
Additional paid-in-capital		505			505
Additional paid in capital		203,120			505
Retained earnings (accumulated deficit)		(42,762	)		(32,751	)
Accumulated earnings (Deficit)		(1,363,636	)		(42,762	)
Total Stockholders' Equity		10,688			20,699
Total Stockholders' Equity (Deficit)		(1,142,686	)		10,688
Total Liabilities and Stockholders' Equity	$	17,688		$	25,699
Total Liabilities and Stockholders' Equity (Deficit)	$	626,369		$	17,688

See accompanying notes to audited financial statements.

21F-4

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

	Year ended			Year ended
	June 30, 2017			June 30, 2016
Revenue
Sub license and service agreements	$	12,000		$	15,000
Pet products		12,200			15,875
Total Revenue		24,200			30,875
Cost of goods sold		7,000			12,000
Gross profit		17,200			18,875
Operating Expenses
Professional fees		16,486			29,825
Advertising and marketing		5,075			6,000
Amortization		4,076			4,076
Consulting		1,500			11,000
General and administrative		74			905
Total Operating Expenses		27,211			51,806
Income (loss) before taxes		(10,011	)		(32,931	)
Income tax expense (benefit)		-			-
Net Income (loss)	$	(10,011	)	$	(32,931	)
Income (loss) Basic and Diluted	$	(0.00	)*	$	(0.00	)*
Weighted Average of Common Shares Outstanding - Basic and Diluted		52,944,500			52,944,500

STATEMENTS OF OPERATIONS

* denotes income or (loss) of less than $0.01 per share

	Year ended			Year ended
Revenue	June 30, 2018			June 30, 2017
Product Sale	$	85,100		$	12,000
Consulting Income		305			-
Shipping Income		1,200			-
Sub license and service agreements		4,500			12,200
Total Revenue		91,105			24,200

Cost of goods sold		58,360			7,000

Gross profit		32,745			17,200

Operating Expenses
Bad Debt		85,100			-
Professional fees		37,276			16,486
Advertising and marketing		7,745			5,075
Amortization		7,576			4,076
Consulting		55,255			1,500
Commission		5,000			-
Rent Expense		5,000
General and administrative		1,376			74
Total Operating Expenses		204,328			27,211
Income (loss) before other expense		(171,583	)		(10,011	)

Other Expense
Change in fair value of derivative		769,394
Interest on convertible notes		379,897
Total Other Expense		1,149,291			-

Net Income (loss)	$	(1,320,874	)	$	(10,011	)

Income (loss) Basic and Diluted	$	(0.05	)	$	(0.00	)*

Weighted Average of Common Shares Outstanding - Basic and Diluted		27,914,425			52,944,500

~~See~~* ~~accompanying~~denotes ~~notes~~income toor ~~audited~~(loss) ~~financial~~of ~~statements~~less than $0.01 per share.

22See accompanying notes to audited financial statements

~~OPTEC INTERNATIONAL, INC.~~F-5

OPTEC INTERNATIONAL, INC

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

	Common Stock Number of Shares (1)			Amount (1)			Additional Paid in Capital (1)			Accumulated Earnings (Deficit)			Total
	Common Stock Number of Shares			Amount			Additional Paid in Capital			Accumulated Earnings (Deficit)			Total
Balance, June 30, 2015		52,944,500		$	52,945		$	505		$	180		$	53,630
Net loss for the year ended June 30, 2016		-			-			-			(32,931	)		(32,931	)
Balance, June 30, 2016		52,944,500		$	52,945		$	505		$	(32,751	)	$	20,699
Net loss for the year ended June 30, 2017		-			-			-			(10,011	)		(10,011	)
Balance, June 30, 2017		52,944,500		$	52,945		$	505		$	(42,762	)	$	10,688
Cancellation of shares		(49,700,000	)		(49,700	)		49,700			-			-
Sale of Common Stock		85,000			85			169,915			-			170,000
Stock Offering Cost								(17,000	)					(17,000	)
Stock Issued for Services to related party		12,000,447			12,000			-			-			12,000
Stock Issued for International Licensing to related party		1,500,000			1,500			-			-			1,500
Stock Issued for North America Licensing to related party		1,000,000			1,000			-			-			1,000
Net Loss June 30, 2018		-			-			-			(1,320,874	)		(1,320,874	)
Balance, June 30, 2018		17,829,947		$	17,830		$	203,120		$	(1,363,636	)	$	(1,142,686	),

(1) As retrospectively restated for the 1:7 forward split completed effective June 1, 2015.

See accompanying notes to audited financial statements.

23F-6

OPTEC INTERNATIONAL, INC.

~~(FORMERLY~~STATEMENTS ~~GREEN~~OF ~~MEADOW~~CASH ~~PRODUCTS, INC.)~~FLOWS

STATEMENT OF CASH FLOWS

	Year Ended			Year Ended
	June 30, 2018			June 30, 2017
Cash Flows from Operating Activities
Net income (loss)	$	(1,320,874	)	$	(10,011	)
Adjustments to Reconcile Net Income (Loss) To Net Cash Provided by (Used In) Operating Activities:
Amortization expense		7,576			4,076
Amortization of debt discount		276.413			-
Changes in fair value of derivative liability		769,394			-
Stock issued for services		12,000			-
Bad debt expense		85,100			-
Changes in Operating Assets and Liabilities
Accounts receivable		(80,400	)		(4,700	)
Inventory		(85,000	)		-
Prepaid Salary-related party		(3,000	)		-
Accounts payable and accrued expenses-related party		53,760			2,000
Accrued interest		3,221			-
Net Cash Provided by (Used in) Operating Activities-		(281,810	)		(8,635	)

Cash Flows from Investing Activities
Note receivable-related party		(109,000	)		-
Net Cash used in Investing Activities		(109,000	)		-

Financing Activities
Proceeds from issuance of notes payable		482,000			-
Loan from related party		100			-
Proceeds from sale of capital stock		170,000			-
Stock Offering Cost		(17,000	)		-
Principal payments on debt		(213,833	)		-
Net Cash Provided by Financing Activities		421,267			-

Increase/Decrease in Cash		30,457			(8,635	)

Cash at Beginning of Period		342			8,977

Cash at End of Period	$	30,799		$	342

Supplemental disclosure
Cash paid for Interest	$	-		$	-
Cash paid for income taxes	$	-		$	-

	Year Ended			Year Ended
	June 30, 2017			June 30, 2016
Cash Flows from Operating Activities
Net income (loss)	$	(10,011	)	$	(32,931	)
Adjustments to Reconcile Net Income (Loss) To Net Cash Provided by (Used In) Operating Activities:
Amortization expense		4,076			4,076
Stock issued for services		-			-
Changes in operating assets and liabilities
Inventory		-			-
Accounts Receivable		(4,700	)
Accounts payable		2,000			4,702
Income tax Benefit		-			(32	)
Net Cash Provided by (Used in) Operating Activities		(8,635	)		(24,185	)
Net Cash Provided by (Used in) Operating Activities		(8,635	)		(24,185	)
Cash Flows from Investing Activities		-			-
Net Cash used in Investing Activities		-			-
Cash Flows from Financing Activities		-			-
Net Cash Provided by Financing Activities		-			-
Increase (decrease) in Cash		(8,635	)		(24,185	)
Cash at Beginning of Year		8,977			33,162
Cash at End of Year	$	342		$	8,977
Supplemental disclosure
Cash paid for Interest	$	-		$	-
Cash paid for income taxes	$	-		$	-

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

See accompanying notes to audited financial statements.

Issuance of stock for licensing rights to related party	$	2,500		$	-
Note receivable forgiveness for payment on note payable
to related party	$	(109,000	)	$	-
Note payable issued for licensing rights to related party	$	500,000		$	-

24See accompanying notes to audited financial statements

F-7

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, ~~2017~~2018 AND ~~2016~~2017

Note 1 – NATURE OF OPERATIONS

Optec International, Inc. (Formerly Green Meadow Products, Inc. "the Company", "~~GMP~~Optec", "we", "us" or "our") was incorporated under the laws of the State of Wyoming on June 22, 2012.

~~Our~~The ~~current~~Company, ~~focus~~subsequent isto onacquiring the ~~sales of~~ licensing rights tofor ~~our~~the ~~Green~~Optimized ~~Meadow~~Fuel PRMaximizer, ~~formula~~the ~~and~~Company’s focus is on the ~~manufacturing~~expansion ~~and~~of the sales of& ~~our~~marketing ~~Green~~of ~~Meadow~~the PROptimized ~~formula~~Fuel Maximizer, ~~both~~concentrating ofprimarily ~~which~~in ~~are~~the ~~organic~~North ~~products~~America region, asfollowed ~~well~~by asexpansion ~~the~~into ~~manufacturing~~other geographic areas subsequent to locating and ~~sales~~contracting ofwith ~~our~~large ~~PawPal~~distributors ~~product~~that ~~and~~already ~~our~~operate ~~recently~~in ~~acquired~~the ~~stress~~automotive ~~relief~~aftermarket ~~formula~~arena. WeIn ~~have~~addition ~~also~~the ~~tested~~Company ~~and~~is ~~sold~~focused ~~organic~~on ~~dog~~aiding ~~treats~~the ~~which~~manufacturer ~~contain~~in ~~our~~obtaining ~~pain~~additional ~~relief~~certifications ~~formula~~from ~~and~~the ~~are~~California ~~currently~~Air ~~seeking~~Resources ~~funding~~Board ~~sources~~(CARB) ~~for~~which, upon receiving should aid in the ~~manufacturing~~sales of the ~~dog~~Optimized ~~treats~~Fuel asMaximizer ~~well~~units asnot ~~our~~only ~~pain~~in ~~relief~~California ~~product~~but ~~for~~nationally ~~dogs~~and internationally as well.

InOn ~~the~~June ~~three~~4, ~~months~~2018 ~~ended~~the ~~March~~Company ~~31,~~entered ~~2017,~~into wean ~~made~~Exclusive aLicensing ~~decision~~Agreement towith ~~review~~Optimized ~~additional~~Fuel ~~potential~~Technologies ~~products~~ for ~~marketing~~the ~~and~~right ~~distribution~~to inexclusively ~~what~~distribute weand ~~consider~~sell ~~to be~~ the ~~“Green~~Optimized ~~Sector” or “environmentally friendly”. As a result we acquired seven Optec~~ Fuel Maximizer ~~devices~~internationally, ~~for~~with ~~vehicles~~the inexception ~~March~~ of ~~2017~~the ~~for~~United ~~testing;~~States ~~comprised~~and ofCanada. 2Consideration HDof ~~Optec Fuel Maximizers~~$501,500 2was ~~Intermediate~~paid ~~Optec Fuel Maximizers, 1 Optec Fuel Maximizer~~ for ~~gas~~the ~~passenger~~licensing ~~cars,~~right 1in ~~Optec~~the ~~Fuel~~form ~~Maximizer~~of ~~for~~one ~~diesel~~million ~~passenger~~five ~~cars.~~hundred ~~The~~thousand ~~Optec~~(1,500,000) ~~Fuel~~shares ~~Maximizer~~of isthe anCompany’s oncommon ~~demand~~shares ~~technology~~valued ~~designed~~at ~~for computer controlled gasoline and diesel engines for improved fuel efficiency while simultaneously reducing harmful emissions~~$.001 Weper ~~believe~~share ~~that the technology can reduce greenhouse gas emissions~~ which inwere ~~turn~~authorized ~~could~~to ~~conceivably~~be ~~aid~~issued into ~~making~~Optimized ~~the~~Fuel ~~air~~Technologies; ~~much healthier~~ in ~~our~~addition ~~cities.~~to ~~Should~~five ~~the~~hundred ~~Company’s~~thousand ~~testing~~dollars of($500,000) ~~the~~to ~~devices~~be ~~prove~~paid toover ~~meet~~ the ~~claims~~course of ~~the~~24 ~~manufacturer~~months wefrom ~~may~~the ~~enter~~date ~~into~~herein; ~~future~~of ~~discussions~~which ~~with Optec for potential licensing rights for~~ the ~~devices.~~Company ~~(For~~has ~~further~~paid ~~information on Optec Products acquired-www~~$109,000.~~optecmpg.com)~~

On June 20, 2018 the Company entered into an Exclusive Licensing Agreement Addendum with Optimized Fuel Technologies for the right to exclusively sell the Optimized Fuel Maximizer worldwide. On June 4, 2018, the Company had entered into an Exclusive Licensing Agreement with Optimized Fuel Technologies for the right to exclusively sell the Optimized Fuel Maximizer internationally, with the exception of the United States and Canada; this agreement extends exclusive marketing right to include North America and Canada. Consideration of $1,000 was paid for the licensing rights under the addendum in the form of one million (1,000,000) shares of the Company’s common shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies. (For further information on Optec Products acquired-www.optecmpg.com)

On August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optimized Fuel Maximizer on a manufacturer direct basis As the Company owns the exclusive licensing rights to sales of the Optimized Fuel Maximizer; per the Royalty agreement dated August 27, 2018 the Company agreed to the acceptance of royalty revenue generated by sales which are made on a manufacturer direct basis.

F-8

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

Note 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows.

BASIS OF PRESENTATION

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company's year-end is June 30.

ESTIMATES

The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS

The Company maintains a cash balance in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of June 30, ~~2017~~2018 or ~~2016~~2017.

CUSTOMER AND PURCHASE CONCENTRATION

During the years ended June 30, ~~2017~~2018 and ~~2016~~2017, the following customers represented ~~more than 10% of~~ the Company’s sales:

	June 30, 2017			June 30, 2016
	June 30, 2018			June 30, 2017
	$		%	$		%
Total licensing revenue		124,~~200~~500	~~50.4~~5		1512,~~000~~200	4850.64
Total product revenue *		1286,~~000~~300	4994.67		1512,~~875~~000	5149.46
Total revenue		24,200	100		30,875	100
Total Consulting Income		305	.3
Total licensing revenue
Total revenue		91,105	100		24,200	100
Customer A		4,500	5.0		~~5,000~~	~~16.1~~
Customer B		731,~~100~~600	2934.47		—7,100	—29.4
Customer C		553,~~100~~500	2158.07		105,~~000~~100	3221.50
Customer D		-560	-.6		-	-
Customer E		-640	-.7		-	-
Concentration total		12,200	50.4		15,000	48.6
Customer F		305	.3		-	-
Concentration total		91,105	100		12,200	50.4

F-9

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

During the years ended June 30, 2018 and 2017, the following vendors represented more than 10% of the Company’s Purchases:

	Year ended June 30, 2018			Year ended June 30, 2017
	$		%	$		%
Product-Optec*		58,360	100		7,000	100
Total Purchases		58,360	100		7,000	100

*100% represents product purchased from Optimized Fuel Technologies, a related party.

INVENTORY

Inventory is recorded at lower of cost or market; cost is computed on a first-in first-out basis. We currently have inventory of $85,000 consisting of Optimized Fuel Maximizer units.

FINANCIAL INSTRUMENTS

Fair value measurements are determined based on the assumptions that market participants would use in pricing an asset or liability. Accounting Standards Codification ("ASC") 820-10 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. ASC 820 establishes a fair value hierarchy that prioritizes the use of inputs used in valuation methodologies into the following three levels:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets. A quoted price in an active market provides the most reliable evidence of fair value and must be used to measure fair value whenever available.

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3: Significant unobservable inputs which reflect a reporting entity's own assumptions about the assumptions that market participants would use for pricing an asset or liability. For example, level 3 inputs would relate to forecasts of future earnings and cash flows used in a discounted future cash flows method.

The recorded amounts of financial instruments, comprising cash, accounts payable and income tax payable, approximate their market values as of June 30, ~~2017~~2018 due to the short term maturities of these financial instruments.

26F-10

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

WEBSITE DEVELOPMENT COSTS

Under ASC350-50, Website Development Costs, costs and expenses incurred during the planning and operating stages of the Company's website are expensed as incurred. Under ASC 350-50, costs incurred in the website application and infrastructure development stages are capitalized by the Company and amortized to expense over the website's estimated useful life or period of benefit which is estimated to be 5 years. The website for the pet products has been fully amortized as of June 30, 2018.

OTHER INTANGIBLE ASSETS

Under ASC 350-50-1, costs incurred in the acquisition of an intangible asset are capitalized by the Company. As of June 30, ~~2017~~2018 and ~~2016~~2017, our intangible ~~asset~~assets are related to the acquisition of the Licensing rights for the Optimized Fuel Maximizer which is being amortized to expense over the licensing rights estimated useful life or period of benefit which is estimated to be 10 years using straight-line method; annual amortization will be approximately $50,250 per year. In addition the purchase of our Green Meadow PR formula for natural pain relief for animals ~~and~~ is being amortized to expense over the formula's estimated useful life or period of benefit which is estimated to be 10 years using straight-line method.

IMPAIRMENT OF LONG-LIVED ASSETS

The Company evaluates the recoverability of long-lived assets and intangible assets and the related estimated remaining lives at each balance sheet date. The Company records an impairment or change in useful life whenever events or changes in circumstances indicate that the carrying amount may not be recoverable or the useful life has changed. At year ended June 30, 2018 there is no impairment of long-lived assets or intangible assets.

INCOME TAXES

We account for income taxes in accordance with FASB ASC 740, Income Taxes which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The effect on the deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

F-11

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

REVENUE RECOGNITION

27The Company's revenues have been generated primarily through the sales of the Optimized Fuel Maximizer units and sublicense and distribution agreements related to our PawPal product and our pain relief products. The terms of these agreements generally consist solely of upfront, nonrefundable payments for licensing and distribution rights. Revenues from non-refundable licensing and distribution fees are recognized upon receipt of the payment if the license has stand-alone value and we do not have ongoing involvement or obligations.

~~The~~For ~~Company's~~the ~~revenues~~years ~~have~~ended ~~been~~June ~~generated~~30, ~~primarily~~2018 ~~through sublicense~~ and ~~distribution~~ ~~agreements~~2017, ~~related~~all tosales ~~our~~and ~~PawPal~~license ~~product~~payments ~~and~~met ~~our~~the ~~pain~~above ~~relief~~criteria ~~products.~~or ~~The~~in ~~terms~~the case of ~~these~~one ~~agreements~~contract, ~~generally~~the ~~consist~~only ~~solely~~continuing ofinvolvement ~~upfront,~~was ~~nonrefundable~~to ~~payments for~~sell ~~licensing~~our ~~and distribution~~products ~~rights. Revenues~~to ~~from~~the ~~non-refundable~~distributor ~~licensing~~at ~~and~~pricing ~~distribution~~that ~~fees~~is ~~are~~consistent ~~recognized~~with ~~upon~~market ~~receipt~~transactions, ofthereby ~~the~~allowing ~~payment~~for if the ~~license~~recognition ~~has~~of ~~stand-alone~~revenue ~~value~~for ~~and~~the welicensing doand ~~not~~distribution ~~have~~arrangements ~~ongoing~~upon ~~involvement or obligations~~receipt.

For the years ended June 30, 2017 and 2016, all license payments met the above criteria or in the case of one contract, the only continuing involvement was to sell our products to the distributor at pricing that is consistent with market transactions, thereby allowing for the recognition of revenue for the licensing and distribution arrangements upon receipt.

TRADE RECEIVABLES

Trade Receivables are the amount of billed or unbilled claims or other similar items subject to uncertainty concerning their determination or ultimate realization under contracts that are expected to be collected in the next rolling twelve months following the latest balance sheet presented. Our policies on receivables varies per customer, but in no case do we allow for a receivable to be outstanding for more than 12 months. As of June 30, ~~2017~~2018, we had ano ~~receivable~~open ~~from Mountain High Products of $100 from an invoice dated December 5, 2016 for 5,100 of which $5,000 was paid leaving a balance of $100 and a~~ receivable ~~of $4,600 from an invoice dated March 10, 2017 from Autovative Technologies, Inc~~. ~~for~~In ~~$12,000 of which $7,400 was paid leaving a balance due of $4,600. Subsequent to~~ the year ended June 30, ~~2017~~2018 ~~all~~we ~~receivables~~expensed ~~have~~$85,100 ~~been~~to ~~paid~~bad indebt ~~full~~as uncollectable receivables.

ADVERTISING COSTS

The Company's policy regarding advertising is to expense advertising when incurred. The Company incurred advertising and marketing expense of $57,~~075~~745 during the year ended June 30, ~~2017~~2018 and $65,~~000~~075 in the year ended ~~2016~~June 30, 2017.

NET INCOME (LOSS) PER SHARE OF COMMON STOCK

The Company computes net income (loss) per share in accordance with ASC 105, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. At year ended June 30, 2018, 177,821 shares, (128,521 from convertible notes and 49,300 from warrants), were potentially dilutive common shares and at year ended June 30, 2017 there were no diluted shares.

The Company has no potentially dilutive debt or equity instruments issued and outstanding during the years ended June 30, 2017 or 2016.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of its operations ~~other than in respect of the early adoption of the new regulations relating to Development Stage Entities as discussed above~~.

28F-12

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

Note 3 – GOING CONCERN

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As at June 30, ~~2017~~2018, the Company had yet to establish a proven, reliable, recurring source of revenue to fund its ongoing operating costs and with insufficient funds to fully implement its proposed business plan. This raises substantial doubt about the Company's ability to continue as a going concern.

The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. The Company is contemplating conducting an offering of its debt or equity securities to obtain additional operating capital. The Company is dependent upon its ability, and will continue to attempt, to secure equity and/or debt financing. There are no assurances that the Company will be successful and without sufficient financing it would be unlikely for the Company to continue as a going concern.

Note 4 –~~LICENSING~~ ~~AND~~LOANS ~~SERVICE AGREEMENTS~~ RECEIVABLE

On ~~September~~November 181, ~~2014,~~2017 ~~we entered into a contract with Eastwinds Holding Corporation ("EWH") for~~ the ~~non-exclusive~~board ~~sub~~of ~~licensing~~Directors ~~rights~~approved toa ~~manufacture~~revolving ~~and~~loan ~~sell~~receivable ~~our Green Meadow PR formula in the United States~~ with ~~the~~a ~~exception~~three ofyear ~~Virginia~~maximum term and ~~North~~a ~~Carolina,~~limit ~~for the sum~~ of $15250,000. ~~There~~to ~~are~~Optimized noFuel ~~future~~Technologies, ~~royalties~~a ~~attached~~related toparty and the ~~sale~~manufacturer of ~~these~~the ~~rights.~~Fuel ~~Under~~Maximizer ~~the~~units ~~terms~~we ofsell. ~~the~~The ~~contract~~loan weis ~~were~~intended ~~required~~ to ~~deliver~~have ~~all~~various ~~details,~~advances ~~digital~~at ~~information,~~a ~~specifications~~0% ~~and~~interest ~~samples~~rate offor the ~~Green~~first ~~Meadow~~90 PRdays ~~formula~~with ~~upon acceptance of~~ the ~~contract~~interest ~~and~~rate ~~upon~~subject ~~receipt~~to ofadjustment ~~the~~thereafter. $15109,000 ~~payment,~~loan ~~which~~was wemade ~~have~~to ~~done.~~facilitate ~~We have no further obligations under~~ the ~~contract.~~additional ~~Accordingly~~CARB we(California ~~have~~Air ~~recognized~~Resources inboard) ~~full~~certifications, ~~the~~Patents ~~$15~~expanded,~~000~~ ~~received~~and ~~from~~other ~~the~~certifications ~~sale~~needed, ofwhich ~~these~~are ~~licensing~~required ~~rights~~for asboth ~~revenue~~domestic ~~during~~and ~~the~~international ~~period~~markets. ~~The~~$109,000 ~~rights~~was ~~have~~paid noin ~~duration~~full oras ~~termination~~an ~~constraints.~~other Inreceivable ato ~~separate~~Optimized ~~agreement~~Fuel ~~dated October 20~~Technologies, ~~2014~~a ~~with~~related ~~Eastwinds~~party, ~~Holding~~which ~~Corporation~~was wecredited ~~entered~~against ~~into~~ a ~~service agreement for~~ $15500,000 tonote ~~assist~~payable ~~East Winds Holding Corporation in the manufacturing process~~ for ~~the~~licensing ~~Green Meadow PR formula which had previously been licensed to East winds Holding Corporation~~rights.

On June 10, 2015, we signed a contract with Wholesale 4 You, Inc. ("Wholesale") whereby Wholesale acquired the exclusive licensing rights to manufacture and sell our stress relief product for the sum of $10,000. There are no future royalties attached to the sale of these rights. Under the terms of the contract we were required to deliver all details, digital information, specifications and samples of our Green Meadow Stress Relief formula upon acceptance of the contract and upon receipt of the $10,000 payment, which we have done. We have no further obligations under the contract. Accordingly we have recognized in full the $10,000 received from the sale of these licensing rights as revenue during the period. On September 15, 2015 we entered into a service agreement for $Note 5~~,000~~ ~~with~~- ~~Wholesale~~CONVERTIBLE ~~4 You, Inc. to assist with the marketing of the stress relief product previously acquired from us.~~LOANS

OnAt ~~December~~June 1730, ~~2015~~2018 weand ~~were paid $10~~2017,~~000~~ byconvertible ~~Mountain~~loans ~~High~~consisted ~~Products, Inc., which was comprised~~ of the assistance of sales of certain of our licensing rights and distribution rights for our pain relief formula for dogs in conjunction with Mountain High Products, Inc.(“MH”) We amended an original contract dated March 28, 2014 with Mountain High Products on November 24, 2015 which allowed us to be paid by MH for assisting in international sales. As such we were paid a $10,000 fee for our assistance.following:

Note 5 - RELATED PARTY TRANSACTIONS

	June 30,			June 30,
	2018			2017
November 7, 2017 Note	$	29,167		$	-
April 30, 2018 Note		112,500			-
June 15, 2018 Note		200,000			-
Total convertible notes payable		341,667			-
Less: Unamortized debt discount		(279,087	)		-
Total convertible notes		48,580			-

Less: current portion of convertible notes		48,580			-
Long-term convertible notes	$	-		$	-

WeDuring ~~entered~~the ~~into~~year anended ~~agreement~~June ~~on January 15~~30, ~~2015~~2018 ~~with~~and ~~our President~~2017, ~~Stanley~~the ~~Windhorn,~~Company ~~for~~recognized aamortization ~~salary~~of todebt bediscount, ~~paid~~included in ~~the~~interest ~~amount~~expense, of $2276,~~000~~413 ~~per~~and ~~month. For the three months ended March 31, 2015,~~ $60,~~000~~ ~~was paid to Mr. Windhorn per the agreement. Subsequently we determined that the revenues generated by the Company were not sufficient to support operations~~ and ainterest ~~salary.~~expense ~~We entered into a new employment agreement on April 1, 2015 which supersedes any past agreements whereby Stan Windhorn under the new agreement will be awarded compensation at the discretion~~ of ~~the Company’s board. The Company has not incurred any salary under this new agreement since April 1~~$103,484 ~~2015~~and to$0 ~~the date of the issuance of this Form 10K~~respectively.

29F-13

~~Note~~OPTEC 6INTERNATIONAL, ~~- INCOME TAXES~~INC.

~~The~~(FORMERLY ~~provision~~GREEN ~~for~~MEADOW ~~income~~PRODUCTS, ~~taxes differs from the amount computed by applying the statutory federal income tax rate to income before provision for income taxes~~INC. ~~The sources and tax effects of the differences for the periods presented at 15% income tax rate are as follows:~~ )

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

Promissory Notes - Issued in fiscal year 2018

During the year ended June 30, 2018, the Company issued a total of $555,500 promissory notes (“Notes”) with the following terms:

Terms ranging from 8 months to 9 months.

Annual interest rates of 10%to 12%.

Convertible at the option of the holders at issuance or 180 days from issuance.

Conversion prices are typically based on the discounted (45% or 50% discount) average closing prices or lowest trading prices of the Company’s shares during various periods prior to conversion.

Certain notes allow the Company to redeem the notes at rates ranging from 135% to 150% depending on the redemption date provided that no redemption is allowed after the 180th day. Likewise, the note includes original issue discounts totaling to $59,500 and the Company received cash of $482,000.

The Company identified conversion features embedded within certain notes and warrants issued during the year ended June 30, 2018. The Company has determined that the conversion feature of the Notes represents an embedded derivative since the conversion price is variable and the Notes include a reset provision which could cause adjustments upon conversion. Accordingly, the Notes are not considered to be conventional debt and the embedded conversion feature must be bifurcated from the debt host and accounted for as a derivative liability. On issuance, the warrants are exercisable into 20,161 and 14,300 shares of common stock, for a period of five years from issuance, at a price of $3.45 and $7 per share, respectively. As a result of the reset features for 20,161 warrant, at June 30, 2018, the warrants increased by 14,839 and the total warrants exercisable into 35,000 shares of common stock at $1.25 per share which are potentially dilutive for loss per share disclosure, but the dilution is immaterial. The reset feature of warrants associated with this convertible note was effective at the time that a separate convertible note with lower exercise price was issued. We accounted for the issuance of the Warrants as a derivative.

Warrants

The assumptions used to calculate the derivative liability associated with warrants as of June 30, 2018:

	St George Warrants			Auctus Warrants
Company’s stock price	$	9.05		$	9.05
Exercise price of the warrant	$	1.25			7.00
The number of periods to exercise the warrants	4.29 years			4.96 years
Risk free rate		2.73	%		2.73	%
Volatility		4.21	%		4.21	%

F-14

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

A summary of activity during the year ended June 30, 2018 regarding warrants issued follows:

	Warrants Outstanding
			Weighted Average
	Shares		Exercise Price

Outstanding, June 30, 2017		-		$	-
Granted		34,461			4.92
Reset feature		14,839			1.25
Exercised		-			-
Forfeited/canceled		-			-
Outstanding, June 30, 2018		49,300		$	2.92

The following table summarizes information relating to outstanding and exercisable warrants as of June 30, 2018:

Warrants Outstanding							Warrants Exercisable
Number of		Weighted Average Remaining Contractual life		Weighted Average			Number of		Weighted Average
Shares		(in years)		Exercise Price			Shares		Exercise Price
	35,000		4.36		$	1.25		35,000		$	1.25
	14,300		4.96		$	7.00		14,300		$	7.00
	49,300		4.53		$	2.92		49,300		$	2.92

Note 6 - DERIVATIVE LIABILITIES

The Company analyzed the conversion option for derivative accounting consideration under ASC 815, Derivatives and Hedging, and hedging, and determined that the instrument should be classified as a liability since the conversion option becomes effective at issuance resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options.

Fair Value Assumptions Used in Accounting for Derivative Liabilities.

ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item.

The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Black-Scholes pricing model to calculate the fair value as of June 30, 2018. The Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note is estimated using the Black-Scholes valuation model.

F-15

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

At June 30, 2018, the estimated fair values of the liabilities measured on a recurring basis are as follows:

	Year Ended			Year Ended
	June 30, 2018			June 30, 2017
Expected term	0.02 - 5.00 years				-
Expected average volatility		12% - 487	%		-
Expected dividend yield		-			-
Risk-free interest rate		1.37% - 2.81	%		-

The following table summarizes the changes in the derivative liabilities during the year ended June 30, 2018:

Fair Value Measurements Using Significant Observable Inputs (Level 3)

Balance - June 30, 2017	$	-

Addition of new derivatives recognized as debt discounts		496,000
Addition of new derivatives recognized as loss on derivatives		825,755
Gain on change in fair value of the derivative		(56,361	)
Balance – June 30, 2018	$	1,265,394

The aggregate loss on derivatives during the years ended June 30, 2018 and 2017 was $769,394 and $0, respectively.

Note 7 –LICENSING AND SERVICE AGREEMENTS

On June 4, 2018 the Company entered into an Exclusive Licensing Agreement with Optimized Fuel Technologies, a related party, for the right to exclusively sell the Optimized Fuel Maximizer internationally, with the exception of the United States and Canada. Consideration of $1,500 was paid for the licensing right in the form of one million five hundred thousand (1,500,000) shares of the Company’s common shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies; in addition to five hundred thousand dollars ($500,000) to be paid over the course of 24 months from the date herein; of which the Company has paid $109,000.

On June 20, 2018 the Company entered into an Exclusive Licensing Agreement Addendum with Optimized Fuel Technologies, a related party, for the right to exclusively sell the Optimized Fuel Maximizer worldwide. On June 4, 2018, the Company had entered into an Exclusive Licensing Agreement with Optimized Fuel Technologies for the right to exclusively sell the Optimized Fuel Maximizer internationally, with the exception of the United States and Canada; this agreement extends exclusive marketing right to include North America and Canada. Consideration of $1,000 was paid for the licensing rights under the addendum in the form of one million (1,000,000) shares of the Company’s common shares valued at $.001 per share which were authorized to be issued to Optimized Fuel Technologies.

F-16

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

Note 8 - INCOME TAXES

The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to income before provision for income taxes. The sources and tax effects of the differences for the periods presented at 25% income tax rate are as follows:

Changes in the cumulative net deferred tax assets consist of the following:

	June 30, 2017				June 30, 2016
	June 30, 2018				June 30, 2017
Net operating loss carry forward		$	660,~~414~~237			$	48,~~913~~942
Valuation allowance			(660,~~414~~327	)			(48,~~913~~942	)
		$	-			$	-

A reconciliation of income taxes computed at the statutory rate of 1525% is as follows:

	June 30, 2017				June 30, 2016
	June 30, 2018				June 30, 2017
Tax Benefit at statutory rate		$	152,~~501~~637			$	~~4,940~~753
Change in Valuation allowance			(152,~~501~~637	)			(~~4,940~~753	)
		$	-			$	-

During the years ended June 30, ~~2017~~2018 and the year ended June 30, ~~2016~~2017, we recognized no tax ~~credit~~credits.

Note 79 - ~~COMMITMENTS~~COMMON ~~AND CONTINGENCIES~~STOCK

Contractual obligation

We entered into an agreement on January 15, 2015 with, Stanley Windhorn, for a salary to be paid in the amount of $2,000 per month. For the three months ended March 31, 2015, $6,000 was paid to Mr. Windhorn per the agreement. Subsequently we determined that the revenues generated by the Company were not sufficient to support operations and a salary. We entered into a new employment agreement on April 1, 2015 which supersedes any past agreements whereby Stan Windhorn under the new agreement will be awarded compensation at the discretion of the Company’s board. The Company has not incurred any salary under this new agreement since April 1, 2015 to the date of the issuance of this Form 10K.

We did not enter into any long term contractual obligations during the years ended June 30, 2017 or 2016.

Litigation

We were not subject to any legal proceedings during the years ended June 30, 2017 or 2016 and no legal proceedings are currently pending or threatened to the best of our knowledge.

Note 8 - COMMON STOCK

The Company is authorized to issue seventy five million shares of common stock with $0.001 par value.

The Company authorized a share split on June 1, 2015 whereby seven shares (7) of the Company’s common shares were issued for every one (1) share issued and outstanding resulting in 52,944,500 shares of common stock issued and outstanding at June 30, 2015. All numbers for shares of common stock disclosed as issued and outstanding in these financial statements have been retrospectively restated to reflect the impact of this forward split.

NoOn October 4, 2017, 49,700,000 shares of common stock were ~~issued~~retired ~~during~~resulting from the ~~twelve~~resignation ~~months~~of ~~ended~~Stan ~~June~~Windhorn ~~30,~~as ~~2017~~an officer and ~~2016~~director and options to purchase 1,000,000 shares of common stock at $5.00 were issued.

As85,000 shares were issued to shareholders pursuant to a private offering at $2.00 per share. On April 24, 2018, five thousand (5,000) shares were issued to Morris. On May 29, 2018 fifty thousand (50,000) shares of common stock were authorized to be issued to Fang Zhang. On June 307, ~~2017~~2018 ~~and~~twenty ~~2016~~five thousand (25,000) ~~there~~shares of common stock were 52authorized to be issued to Kurt & Ellen Baum. On June 12,~~944~~ 2018 five thousand (5,~~500~~000) shares of common stock were authorized to be issued ~~and~~to ~~outstanding~~Ron Jensen.

~~Note 9 – SUBSEQUENT EVENTS~~F-17

~~Management~~OPTEC ~~has reviewed events between June 30~~INTERNATIONAL, ~~2017 to the date that the financials were issued, and other than the following there were no other significant events identified for disclosure~~INC.

On(FORMERLY ~~August~~GREEN ~~28,~~MEADOW ~~2017~~PRODUCTS, ~~the Company filed a Def 14c information statement regarding the Company’s name change from Green Meadow Products, Inc~~INC. ~~to Optec International, Inc.~~)

31NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

On October 4, 2017 four million (4,000,000) shares were authorized to be issued to Marcus Pawson as Vice President of International Sales for services valued at $4,000 ($.001 per share). On June 20, 2018 two million (2,000,000) shares were issued to Marcus Pawson for services valued at $2,000 ($.001 per share).

On October 4, 2017 we entered into an Executive Employment Agreement with Peter Sollenne, CEO, whereby compensation shall be at the rate of $3,000 per month plus a signing bonus of $12,000 which was paid in the form of 12,000,000 shares of restricted common shares of the Company at ($.001per share). On June 20, 2018, 6,000,000 shares were cancelled and an additional 238 shares were issued.

On February 15, 2018 two hundred nine (209) shares were issued to Don Kingman for services rendered.

On June 4, 2018 One million five hundred thousand (1,500,000) shares of common stock authorized and issued to Optemized Fuel Technologies for International Exclusive Licensing.

On June 20, 2018 one million (1,000,000) shares of common stock were authorized to be issued to Optemized Fuel Technologies for North America Licensing.

As of June 30, 2018, there were 17,829,947 shares of common stock issued and outstanding. As of June 30, 2017, there were 52,944,500 shares of common stock issued and outstanding.

No shares of common stock were issued during the twelve months ended June 30, 2017

Note 10 – RELATED PARTY TRANSACTIONS

On October 4, 2017 we entered into an Executive employment Agreement with Peter Sollenne, CEO, whereby compensation shall be at the rate of $3,000 per month plus a signing bonus of $12,000 which was paid in the form of 12,000,000 shares of restricted common shares of the Company at ($.001 per share). On June 20, 2018 6,000,000 shares were returned for cancellation and an additional 238 shares were issued.

On November 1, 2017 the board of Directors approved a revolving loan receivable with a three year maximum term and a limit of $250,000 to Optimized Fuel Technologies, a related party and the manufacturer of the Fuel Maximizer units we sell. The loan is intended to have various advances at a 0% interest rate for the first 90 days with the interest rate subject to adjustment thereafter. $109,000 loan was made to facilitate the additional CARB (California Air Resources board) certifications, Patents expanded, and other certifications needed, which are required for both domestic and international markets. $109,000 was paid in full as an other receivable to Optimized Fuel Technologies, a related party, which was credited against a $500,000 note payable for licensing rights.

On May 1, 2018 the Company entered an office lease to sublet warehouse and office space from Optimized Fuel Technologies. The term of the lease is for 13 months at a monthly rent of $2,500 per month.

On June 4, 2018 One million five hundred thousand (1,500,000) shares of common stock authorized and issued to Optemized Fuel Technologies for International Exclusive Licensing and on June 20, 2018 one million (1,000,000) shares of common stock were authorized to be issued to Optemized Fuel Technologies for North America Licensing, in addition to five hundred thousand dollars ($500,000) to be paid over the course of 24 months from the date herein; of which the Company has paid $109,000.

On August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optimized Fuel Maximizer on a manufacturer direct basis. As the Company owns the exclusive licensing rights to sales of the Optimized Fuel Maximizer; per the Royalty agreement dated August 27, 2018 the Company agreed to the acceptance of royalty revenue generated by sales which were made on a manufacturer direct basis.

F-18

OPTEC INTERNATIONAL, INC.

(FORMERLY GREEN MEADOW PRODUCTS, INC.)

NOTES TO THE AUDITED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

Note 11 – COMMITMENTS AND CONTINGENCIES

We have a twelve month lease for office space at 2721 Loker Avenue West, Carlsbad, CA 92010 for $2,500 per month with Optimized Fuel Technologies, a related party. During the years ended June 30, 2018 total rent expense paid was $5,000 and no rent was paid in 2017.

We pay our CEO a salary of $3,000 per month. During the year ended June 30, 2018 total salary paid was $24,000 and no salary was paid in 2017.

Note 12 – SUBSEQUENT EVENTS

Management has reviewed events between June 30, 2018 to the date that the financials were issued, and other than the following there were no other significant events identified for disclosure.

On August 31, 2018 a note payable to Optimized Fuel Technologies was paid off in the amount of $391,000.

On July 9, 2018 a note payable was issued to Peak One Opportunity Fund in the amount of $110,000 with an interest rate of 0% and maturity date of April 9, 2019.

On July 16, 2018 a note payable was issued to Auctus Funds in the amount of $115,000 with an interest rate of 12% and maturity date of April 16, 2019.

On August 2, 2018 a note payable was issued to Carebourn Capital in the amount of $319,000 with an interest rate of 12% and maturity date of August 2, 2019.

On August 15, 2018 a note payable was issued to Power Up Lending in the amount of $73,000 with an interest rate of 12% and maturity date of May 30, 2019.

On September 7, 2018 a convertible promissory note was issued to BHP Capital NY, Inc in the amount of $84,000 with an interest rate of 12% and maturity date of June 7, 2019. A warrant for common stock was issued for 14,000 shares.

On September 7, 2018 a convertible promissory note was issued to Jefferson St Capital, LLC in the amount of $36,750 with an interest rate of 12% and maturity date of June 7, 2019. A warrant for common stock was issued for 6,125 shares.

On September 10, 2018 a convertible promissory note was issued to Crown Bridge Partners LLC in the amount of $55,000 with an interest rate of 10% and maturity date of September 10, 2019. A warrant for common stock was issued for 7,333 shares.

On September 19, 2018 a convertible promissory note was issued to Morningview Financial LLC in the amount of $100,000 with an interest rate of 10% and maturity date of September 18, 2019. A warrant for common stock was issued for 17,857 shares.

On August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optec Fuel Maximizer on a manufacturer direct basis. As the Company owns the exclusive licensing rights to sales of the Optec Fuel Maximizer; per the Royalty agreement dated August 27, 2018, the Company agreed to the acceptance of royalty revenue generated by sales on a manufacturer direct basis. The Company will receive a royalty for each unit sold and collected. Although the Company’s revenues will be less per the contract, it’s gross profit is anticipated to be higher as it will not have to be subjected to inventory, quality control, freight and staffing for distribution.

Subsequent to year end, the Company has made advances to Optimized Fuel Technologies, a related party, in the total amount of $225,900 pursuant to their revolving loan receivable agreement.

F-19

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

There were no changes or disagreements with Accountants.

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

An evaluation was performed under the supervision of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial and accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Annual Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of June 30, ~~2017~~2018, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms due to material weaknesses in our internal controls described below.

Management's Annual Report on Internal Control Over Financial Reporting.

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Despite these controls, because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Furthermore, smaller reporting companies, like us, face additional limitations. Smaller reporting companies employ fewer individuals and can find it difficult to employ resources for complicated transactions and effective risk management. Additionally, smaller reporting companies tend to utilize general accounting software packages that lack a rigorous set of software controls.

Our management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of June 30, ~~2017~~2018 based on the criteria established in "Internal Control — Integrated Framework" issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management believes that as of June 30, ~~2017~~2018, our internal control over financial reporting was not effective based on those criteria.

This annual report does not include an attestation report of our registered public accounting firm regarding our internal controls over financial reporting. Management's report was not subject to attestation by our registered public accounting firm pursuant to Section 404(c) of the Sarbanes-Oxley Act that permit us to provide only management's report in this annual report.

Inherent Limitations Over Internal Controls.

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Our control systems are designed to provide such reasonable assurance of achieving their objectives. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Management notes the following material weaknesses in internal control: lack of segregation of duties due to limited resources; lack of audit committee; and lack of documentation of internal control process and procedures.

Changes in Internal Control Over Financial Reporting.

We have made no change in our internal control over financial reporting during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Attestation Report of the Registered Public Accounting Firm.

This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management's report in this annual report on Form 10-K.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. EXECUTIVE COMPENSATION.

SUMMARY OF CASH AND CERTAIN OTHER COMPENSATION

Executive Compensation

Summary Compensation Table

Name and Principal Position	~~Year~~	~~Salary~~Year		Salary	~~Bonus~~		Bonus	~~Option Awards~~		Option Awards	~~All Other Compensation~~		All Other Compensation	~~Total~~		Total
Stan Windhorn(1)	~~2015~~	2015	~~6,000~~		6,000	-		-	-		-	-		-	~~6,000~~		6,000
	~~2016~~	2016	-		-	-		-	-		-	-		-	-		-
	~~2017~~	2017	-		-	-		-	-		-	-		-	-		-
Peter Sollenne(2)	~~2017~~	2018	-		39,000	-		-	-		-	-		6,005	-(3)		45,005
		2017			-			-			-			-			-
Marcus Pawson		2018			-			-			-			4,945	(4)		4,945

(1)

Stan Windhorn, Director and CEO, CFO and Secretary since inception-resigned as Director and CEO, CFO on May 24, 2017.

(2) Peter Sollenne, Director and CEO, ~~CFO~~on ~~since~~ May 24, 2017.

~~Option~~(3) ~~Grants~~Peter ~~Table.~~Sollenne, ~~There~~Director ~~were~~and noCEO ~~individual~~was ~~grants~~issued of6,005,000 ~~stock~~shares ~~options~~of ~~to purchase our~~ common restricted stock ~~made~~for ~~to the executive officer named in the Summary Compensation Table through June 30, 2017.~~services

(4)

Marcus Pawson, Vice President of International Sales, was issued 4,945,000 shares of common restricted stock for services

Option Grants Table. There were no individual grants of stock options to purchase our common stock made to the executive officer named in the Summary Compensation Table through June 30, 2018.

Compensation of Officers and Directors

WeOn ~~did~~October ~~not accrue or pay any salaries during the year ended June 30~~4, 2017. Wewe entered into an ~~agreement~~Executive onemployment ~~January~~Agreement ~~15, 2015~~ with, ~~Stanley~~Peter ~~Windhorn~~Sollenne, ~~who was DIRECTOR,~~ CEO, ~~CFO~~whereby ~~and~~compensation ~~SECRETARY~~shall ~~until~~be ~~May 24, 2017~~ at ~~which time he resigned as CEO, Director and CFO but remained as Secretary,for a salary to be paid in~~ the ~~amount~~rate of $23,000 per month. ~~For~~plus ~~the~~a ~~three~~signing ~~months~~bonus ~~ended~~of ~~March 31, 2015,~~ $612,000 which was paid toin ~~Mr. Windhorn per~~ the ~~agreement.~~form ~~Subsequently~~of we12,000,000 ~~determined~~shares ~~that~~of ~~the~~restricted ~~revenues~~common ~~generated~~shares byof the Company ~~were~~at ~~not~~($.001per ~~sufficient to support operations and a salary~~share). On WeJune ~~entered~~20, ~~into~~2018 ~~a new employment agreement on April 1~~6,000,000 ~~2015~~shares ~~which~~were ~~supercedes~~cancelled ~~any~~and ~~past~~an ~~agreements~~additional ~~whereby~~238 ~~Stan~~shares ~~Windhorn~~were ~~under the new agreement will be awarded compensation at the discretion of the Company’s board~~issued. ~~The company has not incurred any salary under this new agreement during the year ended June 30, 2017.~~

~~Employment~~On ~~Agreements~~October 4, 2017 four million (4,000,000) shares were authorized to be issued to Marcus Pawson as Vice President of International Sales for services valued at $4,000 ($.001 per share). On June 20, 2018 two million (2,000,000) shares were issued to Marcus Pawson for services valued at $2,000 ($.001 per share).

We did not accrue or pay any salaries during the year ended June 30, 2017. We entered into an agreement on January 15, 2015 with, Stanley Windhorn, who was DIRECTOR, CEO, CFO and SECRETARY until May 24, 2017 at which time he resigned as CEO, Director and CFO but remained as Secretary, for a salary to be paid in the amount of $2,000 per month. For the three months ended March 31, 2015, $6,000 was paid to Mr. Windhorn per the agreement. Subsequently we determined that the revenues generated by the Company were not sufficient to support operations and a salary. We entered into a new employment agreement on April 1, 2015 which supercedes any past agreements whereby ~~Stanley~~Stan Windhorn under the new agreement will be awarded compensation at the discretion of the Company’s board. The company has not incurred any salary under this new agreement during the year ended June 30, 2017.

~~The Company has not incurred any salary under this new agreement since April 1, 2015 to the date of the issuance of this Form 10K.~~18

ITEM 11. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.

Executive Officers and Directors

The following table and subsequent discussion contains the complete and accurate information concerning our directors and executive officers, their ages, term served and all of our officers and their positions, who will serve in the same capacity with us upon completion of the offering.

Name	Age	Term Served	Title / Position(s)
Stanley Windhorn	50	Since inception, June 22, 2012	CEO, CFO, and Director
		Since May 24, 2017	Secretary
Peter Sollenne	6869	Since May 24, 2017	CEO,CFO and Director
Marcus Pawson	45	Since June 4, 2018	Director

There are no other persons nominated or chosen to become directors or executive officers nor do we have any employees other than above.

Stanley Windhorn has served as the Company's CEO, CFO, Secretary and Director since June 22, 2012. On May 24, 2017, he resigned as Director, CEO and CFO and remained as Secretary of the Company. Stanley Windhorn through his ventures has specialized in marketing to both consumers and businesses, both nationally as well as internationally. He is the Managing Partner and founder of Univative Concepts which is a marketing Company which he has operated since 2005. He was the owner of several Fitness 19 franchises which were sold in 2011. He serves as the Regional Manager for the automobile technology sales company, True Car. We believe his marketing skill sets will bring a distinct advantage to the Company's ability to move forward.

Mr. Sollenne, was appointed as Director, CEO and CFO on May 24, 2017. Mr. Sollenne age 68, has served as the President and CFO of Blackhawk Wealth Group, Inc. a financial advisory company from 2008 to the present where he administered the strategic financial planning for numerous companies, inclusive of the medical device industry, oil & gas industry and the international commodity trading arena, to name a few. From 2003 to 2008 Mr. Sollenne served as the CEO and CFO of IT&E International, Inc. an international life sciences services company serving the ~~Pharmacutical~~Pharmaceutical, Biotech, Biopharma and clinical research industries. From May 2000 to December 2003, Mr. Sollenne was President and Chief Executive Officer at ~~FastBreak~~Fast Break Growth, Inc. a strategic management consulting and business solutions company. From December 1998 to May 2000, Mr. Sollenne was Chief Executive Officer, President and Chief Operating Officer of re-Solutions, Inc., an information technology professional services company. Mr. Sollenne received his Bachelors of Science in Accounting/Business Administration from Boston College and is a CPA.

Mr. Pawson was appointed as Director, and Vice President of International Distribution on June 4, 2018. Mr. Pawson age 45, has an extensive background in production and distribution of tooling, generators, and all types of combustion engines and accessories, all in the United Kingdom. His experiences have been to Manage production & service facilities and also has experience in International Distribution. He was Branch Manager for Hire Station from 1996-2006; then became Territory Manager for Speedy Hire for over 11 years, overseeing 10 branches and the entire South Yorkshire, both large manufacturers and distributors of production tooling, generators, excavators and related equipment. Previous to this appointment, he served with Optimized Fuel Technologies as a lead engineer in the testing and development of the Fuel Maximizer product line. He was instrumental in the development of the Fuel Maximizer products, and was the key engineer on the Motor Cycle Fuel Maximizer. He subsequently resigned from Optimized Fuel Technologies when he was appointed to the Board and Vice President of International Distribution for OPTEC International, Inc.

Our directors will hold office until the next annual meeting of shareholders and the election and qualification of their successors. Directors receive no compensation for serving on the board of directors other than reimbursement of reasonable expenses incurred in attending meetings. Officers are appointed by the board of directors and serve at the discretion of the board.

No officer, director, or persons nominated for such positions and no promoters or significant employee of GMP has been involved in legal proceedings that would be material to an evaluation of officers and directors.

Indemnification of Directors and Officers

Except as permitted by the Wyoming Revised Statutes, the Company's Articles of Incorporation do not provide for any additional or different indemnification procedures. At present, there is no pending litigation or proceeding involving a director, officer or employee of the Company regarding which indemnification is sought, nor is the Company aware of any threatened litigation that may result in claims of indemnification. The Company has not obtained director's and officer's liability insurance, although the board of directors of the Company may determine to investigate and, possibly, acquire such insurance in the future.

Conflict of Interest - Management's Fiduciary Duties

Our directors and officer or may become, in their individual capacity, officers, directors, controlling shareholders and/or partners of other entities engaged in a variety of businesses.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

None

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth, as of June 30, ~~2017~~2018, information concerning ownership of our securities by:

Each person who owns beneficially more than five percent of the outstanding shares of our common stock;

Each person who owns beneficially more than five percent of the outstanding shares of our preferred stock;

Each director;

Each named executive officer; and

All directors and officers as a group.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The table below sets forth, as of June 30, ~~2016 and June 30~~2018, ~~2017,~~ certain information with respect to the beneficial ownership of the common stock of our Company by each person who we know to be beneficial owner of more than 5% of any class or series of our capital stock, each of the directors and executive officers individually, and all directors and executive officers as a group. Unless otherwise indicated, each person named in this table has sole voting and investment power with respect to the shares beneficially owned.

Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Ownership	Percent of Class As of June 30, 2018
Common	~~Stanley~~Peter ~~Windhorn~~Sollenne	496,~~700~~005,000*	9434%
Common	~~Peter~~Marcus ~~Sollenne~~Pawson	-4,945,000	-28%
Common	Optimized Fuel Technologies	2,500,000	14%
All executive officers and directors as a group (2 persons)		10,950,000	62%

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

We entered into an agreement on January 15, 2015 with our former President, Stanley Windhorn, for a salary to be paid in the amount of $2,000 per month. For the three months ended March 31, 2015, $6,000 was paid to Mr. Windhorn per the agreement. Subsequently we determined that the revenues generated by the Company were not sufficient to support operations and a salary. We entered into a new employment agreement on April 1, 2015 which supersedes any past agreements whereby Stanley Windhorn under the new agreement will be awarded compensation at the discretion of the Company’s board. The Company has not incurred any salary under this new agreement since April 1, 2015 to the date of the issuance of this Form 10K.

36On October 4, 2017 we entered into an Executive employment Agreement with Peter Sollenne, CEO, whereby compensation shall be at the rate of $3,000 per month plus a signing bonus of $12,000 which was paid in the form of 12,000,000 shares of restricted common shares of the Company at ($.001 per share). On June 20, 2018 6,000,000 shares were returned for cancellation and 238 shares were issued.

The Company currently has an office & warehouse lease agreement for space located at 2721 West Loker Avenue, Carlsbad, CA 92010. Our telephone number at that address is (760) 444-5566. On May 1, 2018 the Company entered an office lease to sublet warehouse and office space from Optimized Fuel Technologies, a related party. The term of the lease is for 13 months at a monthly rent of $2,500 per month.

On August 8, 2018 Optimized Fuel Technologies, a related party, entered into a contract with a company that desired to purchase the Optimized Fuel Maximizer on a manufacturer direct basis. As the Company owns the exclusive licensing rights to sales of the Optimized Fuel Maximizer; per the Royalty agreement dated August 27, 2018 the Company agreed to the acceptance of royalty revenue generated by sales which are made on a manufacturer direct basis.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Audit Fees

For the Company's fiscal years ended June 30, ~~2017~~2018 and ~~2016~~2017, we were billed approximately $121,~~023~~500 in ~~2017and~~2018 and $312,~~000~~023 in ~~2016~~2017 by ~~Prichett~~Pritchett, Siler & Hardy, P. C. and for the Company's fiscal years ended June 30, 2018, we were billed approximately $78,~~500~~023 by ~~Cutler~~Haynie ~~and~~& ~~Co.~~Company ~~LLC,~~and nothing in ~~2016~~ 2017 for professional services rendered for the audit and reviews of our financial statements.

Audit Related Fees

For the Company's fiscal years ended June 30, ~~2017~~2018 and ~~2016~~2017, we were not billed for professional services related to our audits, other than the fees discussed in Audit Fees above.

Tax Fees

For the Company's fiscal years ended June 30, ~~2017~~ 2018 and ~~2016~~2017, we were not billed for professional services rendered for tax compliance, tax advice, and tax planning by our auditors.

All Other Fees

The Company did not incur any other fees related to services rendered by our principal accountant for the fiscal years ended June 30, ~~2017~~2018 and ~~2016~~2017.

ITEM 15. EXHIBITS AND REPORTS ON FORM 8-K.

The following documents are filed as part of this report:

Financial Statements and Financial Statement Schedules

The financial statements are included in Item 8 of this Form 10-K.

Exhibits Required by Item 601 of Regulation S-K

Exhibit No.	Description
31.1	Certification of President, Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.#
32.1	Certification of President, Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .#
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.

# Filed herewith.

3722

SIGNATURES

Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	OPTEC INTERNATIONAL, INC. (FORMERLY GREEN MEADOW PRODUCTS, INC.)
Dated: September 28, 2017	By:	/s/ Peter Sollenne
Dated: October 12, 2018	By:	/s/ Peter Sollenne
		Peter Sollenne,
		CEO, CFO and Director (Principal Executive, Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

SIGNATURE	TITLE	DATE
/s/ Peter Sollenne	Director, CEO, CFO (Principal Executive, Financial and Accounting Officer)	~~September~~October 2812, ~~2017~~2018
Peter Sollenne

3823

Filing Compare · Optec International, Inc.